{
  "data": [
    [
      "-",
      "Ribavirin",
      "-",
      "109.5",
      "-",
      ">400",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Nafamostat",
      "Buipel",
      "22.5",
      "-",
      ">100",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Penciclovir",
      "-",
      "95.96",
      "-",
      ">400",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Nitazoxanide",
      "-",
      "2.12",
      "-",
      "35.53",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "1.13",
      "-",
      ">100",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Remdesivir ",
      "GS5734",
      "0.77",
      "-",
      ">100",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Favipiravir",
      "T-705",
      "61.88",
      "-",
      ">400",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "-",
      "Camostat",
      "Camostat Mesilate, FOY-305, Foipan, Camostat Mesylate",
      "-",
      "Active",
      "-",
      "Munich 929 ",
      "Calu-3",
      "0.001",
      "RT-qPCR",
      "CellTiter-Glo Luminescent CellViability Assay (Promega)",
      "https://doi.org/10.1016/j.cell.2020.02.052"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "Quensyl, Plaquenil, Hydroquin, Dolquine, Quinoric",
      "0.72",
      "-",
      "-",
      "C-Tan-nCoV Wuhan strain 01",
      "Vero",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1093/cid/ciaa237"
    ],
    [
      "-",
      "Chloroquine",
      "Resochi",
      "5.47",
      "-",
      "-",
      "C-Tan-nCoV Wuhan strain 01",
      "Vero",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1093/cid/ciaa237"
    ],
    [
      "-",
      "Apilimod",
      "-",
      "0.023",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "Z LVG- CHN2",
      "-",
      "0.19",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "MDL 28170",
      "-",
      "0.22",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "VBY-825",
      "-",
      "~0.3",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "ONO 5334",
      "-",
      "~0.5",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "Remdesivir ",
      "-",
      "0.62",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "AMG-2674",
      "-",
      "~0.95",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "HanfangchiA",
      "-",
      "~1.1",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "YH-1238",
      "-",
      "~0.95",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "MLN-3897",
      "-",
      "0.14",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "SDZ-62-434",
      "-",
      "0.75",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "SB-616234-A",
      "-",
      "~1.2",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "8(3-chlorostyryl)caffeine",
      "-",
      "1.6",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "N-tert-Butylisoquine",
      "-",
      "~1.2",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "SL-11128",
      "-",
      "~0.25",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "Elopiprazole",
      "-",
      "~1.1",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "Astemizole",
      "-",
      "~1.1",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "KW8232",
      "-",
      "~1.2",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "-",
      "1-Deoxynojirimycin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "4E1RCat",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "4E2RCat",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "4EGI-1",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "4EGI-1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "ABBV-744",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "ABBV-744",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "AC-55541",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "AC-55541",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Apicidin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Apicidin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "AZ3451",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "AZ3451",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Azithromycin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Bafilomycin A1",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Bafilomycin A1",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "BD1008",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Camostat",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Camostat",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Captopril",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Captopril",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Carbapentane",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "CB5083",
      "-",
      "-",
      "Agonist",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Chloramphenicol",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Clemastine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Clemastine",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Cloperastine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Cloperastine",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "CPI-0610",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "CPI-0610",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Daunorubicin",
      "-",
      "-",
      "Agonist",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Daunorubicin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "DBeQ",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "dBET6",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "dBET6",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Dextromethorphan",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Dextromethorphan",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "E-52862",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "E-52862",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "H-89",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "H-89",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Haloperidol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Haloperidol",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ifenprodil",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Indomethacin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Indomethacin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "JQ1",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "JQ1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Lisinopril",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Lisinopril",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Loratadine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Loratadine",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Lovastatin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Luminespib",
      "-",
      "-",
      "U-shaped response",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Merimepodib",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Merimepodib",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Metformin",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Metformin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Midostaurin",
      "-",
      "-",
      "Agonist",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Midostaurin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Minoxidil",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "ML240",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "ML240",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Mycophenolic Acid",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Mycophenolic Acid",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "MZ1",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "MZ1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Nafamostat",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Nafamostat",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Nitazoxanide",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Olanzapine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Onalespib",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Pazopanib",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Pazopanib",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PB28",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PB28",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PD-144418",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PD-144418",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Pepstatin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PF-846",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PF-846",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Pimozide",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Pioglitazone",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ponatinib",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ponatinib",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Progesterone",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PS3061",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "PS3061",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Quercetin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "RapaLink-1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Rapamycin",
      "Sirolimus",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Rapamycin",
      "Sirolimus",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Rimcazole",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Brivudine",
      "RP101",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Brivudine",
      "RP101",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "RS-PPCC",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "RS-PPCC",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ruxolitinib",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ruxolitinib",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "RVX-208",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "RVX-208",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Sapanisertib",
      "INK128, MlN128",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Sapanisertib",
      "INK128, MlN128",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Silmitasertib",
      "CX-4945",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Siramesine",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "S-verapamil",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "S-verapamil",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ternatin 4",
      "DA3",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Ternatin 4",
      "DA3",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Tomivosertib",
      "eFT-508",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Tomivosertib",
      "eFT-508",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Valproic Acid",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Valproic Acid",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "XL413",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Zotatifin",
      "eFT226",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "Zotatifin",
      "eFT226",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "-",
      "N3",
      "-",
      "16.77",
      "-",
      "133",
      "Patient Isolate",
      "Vero E6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1038/s41586-020-2223-y"
    ],
    [
      "-",
      "Ebselen",
      "-",
      "4.67",
      "-",
      "-",
      "Patient Isolate",
      "Vero E6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1038/s41586-020-2223-y"
    ],
    [
      "-",
      "Cinanserin",
      "-",
      "20.61",
      "-",
      ">200",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41586-020-2223-y"
    ],
    [
      "-",
      "Abemaciclib",
      "-",
      "6.62",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Abemaciclib",
      "-",
      "43.7",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Amodiaquine Dihydrochloride 5.15",
      "-",
      "5.15",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Amodiaquine Dihydrochloride 5.15",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Anidulafungin",
      "-",
      "4.64",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Anidulafungin",
      "-",
      "17.23",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Bazedoxifene",
      "-",
      "3.44",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Bazedoxifene",
      "-",
      "12.63",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Berbamine Hydrochloride",
      "-",
      "7.87",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Berbamine Hydrochloride",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Cepharanthine",
      "-",
      "4.47",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Cepharanthine",
      "-",
      "30",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "7.28",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "69.2",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "4.33",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "10.6",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "5.82",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "4.69",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Digitoxin",
      "-",
      "0.23",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Digitoxin",
      "-",
      "0.16",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Digoxin",
      "-",
      "0.19",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Digoxin",
      "-",
      "0.72",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Eltrombopag",
      "-",
      "8.27",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Eltrombopag",
      "-",
      "8.38",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Gilteritinib",
      "-",
      "6.76",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Gilteritinib",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Hexachlorophene",
      "-",
      "0.9",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Hexachlorophene",
      "-",
      "1.48",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Hydroxyprogesterone Caproate",
      "-",
      "6.3",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Hydroxyprogesterone Caproate",
      "-",
      "3.87",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Ivacaftor",
      "-",
      "6.57",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Ivacaftor",
      "-",
      "11.55",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Loperamide Hydrochloride",
      "-",
      "9.27",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Loperamide Hydrochloride",
      "-",
      "12.53",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Lopinavir",
      "-",
      "9.12",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Lopinavir",
      "-",
      "21.7",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Mefloquine",
      "-",
      "4.33",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Mefloquine",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Nafamostat Mesylate",
      "-",
      "0.0022",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Nafamostat Mesylate",
      "-",
      "13.88",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.28",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.84",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Ouabain",
      "-",
      "<0.1 ",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Ouabain",
      "-",
      "<0.1",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Oxyclozanide",
      "-",
      "3.71",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Oxyclozanide",
      "-",
      "6.78",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Proscillaridin",
      "-",
      "2.04",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Proscillaridin",
      "-",
      "5.95",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.3",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "11.41",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Salinomycin Sodium",
      "-",
      "0.24",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Salinomycin Sodium",
      "-",
      "0.5",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Tetrandrine",
      "-",
      "3",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Tetrandrine",
      "-",
      "13.5",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "-",
      "Cycloheximide",
      "-",
      "0.17",
      "-",
      ">0.5",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "-",
      "Emetine",
      "-",
      "0.47",
      "-",
      ">1",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "-",
      "Pladienolide B",
      "-",
      "0.0013",
      "-",
      "0.007",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "-",
      "2-Deoxy-D-glucose",
      "-",
      "0.41",
      "-",
      "9.09",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "-",
      "NMS-873",
      "-",
      "0.025",
      "Toxic?",
      "0.025",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      "0.07",
      "Toxic?",
      "0.07",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "-",
      "Retro-2.1",
      "-",
      "0.4909",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "1.03",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "-",
      "N-Nonyl  Deoxynojirimycin",
      "NN-DNJ",
      "1.677",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "-",
      "URMC-099-C",
      "-",
      "0.335",
      "-",
      "13.1",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.842",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "-",
      "Favipiravir",
      "T-705",
      "207.1",
      "-",
      ">500",
      "strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Blue\u00ae reagent",
      "https://doi.org/10.1101/2020.05.15.098731"
    ],
    [
      "-",
      "Miglustat",
      "Zavesca; N-butyl-1-deoxynojirimycin, NB-DNJ",
      "41\u00b122",
      "-",
      ">1000",
      "strain ICGEB-FVG_5",
      "Vero E6",
      "30 viral PFU/48-well",
      "Plaque assay",
      "alamar blue",
      "https://doi.org/10.1101/2020.05.18.101691"
    ],
    [
      "-",
      "Oseltamivir Carboxylic Acid",
      "-",
      ">100",
      "Inactive",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.15.20102392"
    ],
    [
      "-",
      "GZ-161",
      "-",
      "~2",
      "-",
      "-",
      "GISAID accession EPI_ISL_406862",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "XXT single conc.",
      " https://doi.org/10.1101/2020.05.18.103283"
    ],
    [
      "-",
      "GZ-346",
      "-",
      "~2",
      "-",
      "-",
      "GISAID accession EPI_ISL_406863",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "XXT single conc.",
      " https://doi.org/10.1101/2020.05.18.103283"
    ],
    [
      "-",
      "Gemcitabine",
      "-",
      "1.24",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "Lycorine",
      "-",
      "0.31",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "Oxysophoridine",
      "-",
      "0.18",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "1.36",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "Gemcitabine",
      "-",
      "-",
      "Active",
      "-",
      "WIV04",
      "Huh-7",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "Lycorine",
      "-",
      "-",
      "Active",
      "-",
      "WIV04",
      "Huh-7",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "Oxysophoridine",
      "-",
      "-",
      "Active",
      "-",
      "WIV04",
      "Huh-7",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "-",
      "ROC-325",
      "-",
      "3.28",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "Clomipramine",
      "-",
      "13.6",
      "-",
      ">30",
      "USA-WA1/2021",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "Hycanthone",
      "-",
      "5.79",
      "-",
      "14",
      "USA-WA1/2022",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "Verteporfin",
      "-",
      "-",
      "Inactive",
      ">30",
      "USA-WA1/2023",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "2.01",
      "-",
      ">30",
      "USA-WA1/2024",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "4.47",
      "-",
      ">30",
      "USA-WA1/2025",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "Mefloquine",
      "-",
      "3.85",
      "-",
      "8.78",
      "USA-WA1/2026",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "7.04",
      "-",
      "-",
      "USA-WA1/2027",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "-",
      "CbAE-1",
      "-",
      "0.7344",
      "-",
      "653.1",
      "pseudo SARS-CoV-2",
      "HEK-293T-ACE2",
      "-",
      "Neutralization Assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "-",
      "CbAE-1",
      "-",
      "2.991",
      "-",
      "653.1",
      "-",
      "Vero",
      "-",
      "Plaque assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "-",
      "CbAE-2",
      "-",
      "1.041",
      "-",
      ">1000",
      "pseudo SARS-CoV-2",
      "HEK-293T-ACE2",
      "-",
      "Neutralization Assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "-",
      "CbAE-2",
      "-",
      "2.49",
      "-",
      ">1000",
      "-",
      "Vero",
      "-",
      "Plaque assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "-",
      "Simeprevir",
      "-",
      "4.082",
      "-",
      "19.33",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      " https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "4.269",
      "-",
      ">200",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Bromocriptine Mesylate",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Bictegravir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Entecavir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Zidovudine",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Sofosbuvir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Atovaquone",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Daclatasvir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Saquinavir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Asunaprevir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "-",
      "Chloroquine Diphosphate, Racemic",
      "-",
      "1.801",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "R-Chloroquine Diphosphate",
      "-",
      "1.975",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "S-Chloroquine Diphosphate",
      "-",
      "1.761",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "HydroxyChloroquine Sulfate, Racemic",
      "-",
      "1.752",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "R-HydroxyChloroquine Sulfate",
      "-",
      "2.445",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "S-HydroxyChloroquine Sulfate",
      "-",
      "1.444",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "Azithromycin",
      "-",
      "~10",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "-",
      "Amiodarone",
      "-",
      "0.052",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Bosutinib",
      "-",
      "0.02",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Clofazamine",
      "-",
      "0.084",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Gilteritinib",
      "-",
      "0.224",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Verapamil",
      "-",
      "0.533",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Thioguanine",
      "-",
      "0.216",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Z-FA-FMK",
      "-",
      "0.107",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Metociopramide",
      "-",
      "0.468",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "S1RA",
      "-",
      "0.222",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Entecavir",
      "-",
      "0.042",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.006",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.142",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Fedratinib",
      "-",
      "0.024",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Lomitapide",
      "-",
      "0.766",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Lactoferrin",
      "-",
      "0.308",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "-",
      "Interferon-\u03b21A",
      "IFN-\u03b21a",
      "0.76 IU/ml",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero",
      "0.01",
      "TCID50",
      "-",
      "https://doi.org/10.1016/j.antiviral.2020.104811"
    ],
    [
      "-",
      "Interferon-\u0251",
      "IFN-\u03b1",
      "1.35 IU/ml\u00a0",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero",
      "0.01",
      "TCID50",
      "-",
      "https://doi.org/10.1016/j.antiviral.2020.104811"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.826",
      "-",
      ">20",
      "Wuhan-Hu-1 isolate",
      "Vero E6",
      "0.025",
      "Immunofluorescence",
      "MTT",
      "https://doi.org/10.21203/rs.3.rs-30934/v1"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "0.733",
      "-",
      ">20",
      "Wuhan-Hu-1 isolate",
      "Vero E6",
      "0.025",
      "Immunofluorescence",
      "MTT",
      "https://doi.org/10.21203/rs.3.rs-30934/v1"
    ],
    [
      "-",
      "Famotidine",
      "-",
      ">100",
      "-",
      ">100",
      "Wuhan-Hu-1 isolate",
      "Vero E6",
      "0.025",
      "Immunofluorescence",
      "MTT",
      "https://doi.org/10.21203/rs.3.rs-30934/v1"
    ],
    [
      "-",
      "Ivermectin",
      "-",
      "2.2 - 2.8",
      "-",
      "-",
      "Australia/VIC01/2020",
      "Vero/hSLAM",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.antiviral.2020.104787"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.38",
      "-",
      ">100 ",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "Cytopathic effect by MTT",
      "Rotitest Vital",
      "https://doi.org/doi:10.1016/j.ijid.2020.05.085"
    ],
    [
      "-",
      "Darunavir",
      "-",
      ">100",
      "Inactive",
      ">100 ",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "Cytopathic effect by MTT",
      "Rotitest Vital",
      "https://doi.org/doi:10.1016/j.ijid.2020.05.085"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "23.15, 26.9",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Lopinavir",
      "-",
      "26.63, 26.10",
      "-",
      "49.75",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Homorringtonine",
      "-",
      "2.55, 2.14",
      "-",
      "59.75",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Emetine Hydrochloride",
      "-",
      "0.46, 0.50",
      "-",
      "56.46",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      ">500",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Galidesivir",
      "-",
      ">100",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Favipiravir",
      "-",
      ">100",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Oseltamivir Carboxylate",
      "-",
      ">100",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Baloxivir",
      "-",
      ">100",
      "-",
      "85.9",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "R-1479",
      "-",
      ">100",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Tenofovor",
      "-",
      ">100",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Fludarabine",
      "-",
      ">100",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Ritonavir",
      "-",
      ">100",
      "-",
      "48.91",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "-",
      "Cetilistat",
      "-",
      "1.13",
      "-",
      ">100.00",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Diiodohydroxyquinoline",
      "-",
      "1.38",
      "-",
      ">100.00",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Abiraterone Acetate",
      "-",
      "1.94",
      "-",
      "92.35",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Bexarotene",
      "-",
      "2.01",
      "-",
      "38.21",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Cetilistat",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Diiodohydroxyquinoline",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Abiraterone Acetate",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Bexarotene",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "-",
      "Clomiphene Citrate",
      "-",
      "9.73",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "-",
      "Vortioxetine",
      "-",
      "8.03",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "-",
      "Vortioxetine Hydrobromide",
      "-",
      "28.11",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "-",
      "Asenapine",
      "-",
      "16.7",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "-",
      "Chloroquine Diphosphate",
      "-",
      "5.33",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "-",
      "GC376",
      "-",
      "0.18",
      "-",
      ">200",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "cell counting kit-8 (GK10001, GLPBIO)",
      "https://doi.org/10.1101/2020.06.07.138677"
    ],
    [
      "-",
      " 25-Hydroxy-cholesterol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "HEK293-hACE2",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.08.141077"
    ],
    [
      "-",
      "7\u0251,25-Dihydroxy-cholesterol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "HEK293-hACE2",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.08.141077"
    ],
    [
      "-",
      "Fluoxtine",
      "-",
      "2.5ng/ml",
      "-",
      "-",
      "Patient Isolate",
      "Vero",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.14.150490"
    ],
    [
      "-",
      "Lasalocid",
      "-",
      "0.36",
      "-",
      "24",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Salinomycin",
      "-",
      "0.097",
      "-",
      "26",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Monensin",
      "-",
      "0.097",
      "-",
      "26",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Nanchangmycin",
      "-",
      "0.066",
      "-",
      "7.2",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Ionomycin",
      "-",
      "3",
      "-",
      "15",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Calcimysin",
      "-",
      "0.26",
      "-",
      "4.7",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "X-206",
      "-",
      "0.014",
      "-",
      "8.2",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Indanomycin",
      "-",
      "0.63",
      "-",
      "30",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Nigericin",
      "-",
      "0.089",
      "-",
      "7.4",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Maduramycin",
      "-",
      "0.064",
      "-",
      "20",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Naracin",
      "-",
      "0.071",
      "-",
      "7.4",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "HL201",
      "-",
      "2.4",
      "-",
      "11",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "-",
      "Boceprevir",
      "-",
      "0.58",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "Boceprevir",
      "-",
      "1.95",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "Calpain inhibitor II",
      "-",
      "2.07",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "Calpain inhibitor II",
      "-",
      "3.7",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "Calpain inhibitor XII",
      "-",
      "0.49",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "Calpain inhibitor XII",
      "-",
      "0.78",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "GC-376",
      "-",
      "3.37",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "GC-376",
      "-",
      "3.14",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "-",
      "Amprenavir",
      "-",
      "31.32",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Darunavir",
      "-",
      "46.41",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Indinavir",
      "-",
      "59.14",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Tipranavir",
      "-",
      "13.34",
      "-",
      "76.8",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Ritonavir",
      "-",
      "8.63",
      "-",
      "74.11",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Saquinavir",
      "-",
      "8.83",
      "-",
      "44.43",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Atazanavir",
      "-",
      "9.36",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Lopinavir",
      "-",
      "5.73",
      "-",
      "74.44",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "Nelfinavir",
      "-",
      "1.13",
      "-",
      "24.32",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "-",
      "CPI1155",
      "-",
      "8.4",
      "-",
      ">40",
      "USA-WA1/2020",
      "HeLa166 ACE2",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.16.154765"
    ],
    [
      "-",
      "CPI1062",
      "-",
      "0.54",
      "-",
      ">40",
      "USA-WA1/2020",
      "HeLa166 ACE2",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.16.154765"
    ],
    [
      "-",
      "ATN-161",
      "-",
      "3.16",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.15.153387"
    ],
    [
      "-",
      "Daclatasvir",
      "-",
      "0.8",
      "-",
      "31",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Daclatasvir",
      "-",
      "0.6",
      "-",
      "28",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Daclatasvir",
      "-",
      "1.1",
      "-",
      "38",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Sofosbuvir",
      "-",
      ">1",
      "-",
      "360",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Sofosbuvir",
      "-",
      "6.2",
      "-",
      "381",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Sofosbuvir",
      "-",
      "9.5",
      "-",
      "512",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      "6.5",
      "-",
      "142",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      "8.6",
      "-",
      "160",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "1.3",
      "-",
      "268",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Lopinavir/Ritonavir",
      "-",
      "3.3",
      "-",
      "291",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Lopinavir/Ritonavir",
      "-",
      "2.9",
      "-",
      "328",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Lopinavir/Ritonavir",
      "-",
      "4.2",
      "-",
      "256",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "-",
      "Aloxistatin",
      "-",
      "0.3",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Aloxistatin",
      "-",
      "26",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Aloxistatin",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "AM-1241",
      "-",
      "0.008",
      "-",
      "24",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "AM-1241",
      "-",
      "16.7",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "AM-1241",
      "-",
      "20",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Amodiaquine",
      "-",
      "0.58",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Amodiaquine",
      "-",
      "1.617",
      "-",
      "35.79",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Amodiaquine",
      "-",
      "22.39",
      "-",
      "100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Apilimod",
      "-",
      "<0.003 ",
      "-",
      "25.168",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Apilimod",
      "-",
      "0.007",
      "-",
      "12.08",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Apilimod",
      "-",
      "4.543",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "AZD8055",
      "-",
      "1.1",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "AZD8055",
      "-",
      "1.1",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "AZD8055",
      "-",
      "0.003",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Azilsartan",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Azilsartan",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Azilsartan",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Bemcentinib",
      "-",
      "2.1",
      "-",
      "16.4",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Bemcentinib",
      "-",
      "0.1",
      "-",
      "4.7",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Bemcentinib",
      "-",
      "0.47",
      "-",
      "1.6",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "BIX01294",
      "-",
      "0.09",
      "-",
      "12.3",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "BIX01294",
      "-",
      "0.48",
      "-",
      "14.8",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "BIX01294",
      "-",
      "4.9",
      "-",
      "11.5",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Camostat",
      "-",
      ">100",
      "-",
      ">100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Camostat",
      "-",
      ">100",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Camostat",
      "-",
      "0.35",
      "-",
      ">100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cepharanthine",
      "-",
      "0.01",
      "-",
      "21",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cepharanthine",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cepharanthine",
      "-",
      "20.6",
      "-",
      "42.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "0.85",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "5.03",
      "-",
      "99.76",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "25.53",
      "-",
      "100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin A",
      "-",
      "1",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin A",
      "-",
      "2.2",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin A",
      "-",
      "19.55",
      "-",
      "47.39",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin B",
      "-",
      "2.6",
      "-",
      "32.6",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin B",
      "-",
      "3.1",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin B",
      "-",
      "25.22",
      "-",
      "20.45",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin C",
      "-",
      "5.4",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin C",
      "-",
      "8.4",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin C",
      "-",
      "38.45",
      "-",
      "44.43",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin H",
      "-",
      "8",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin H",
      "-",
      "11.9",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporin H",
      "-",
      "35.08",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "0.24",
      "-",
      ">50 ",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "0.9",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "1.5",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "0.87",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Cyclosporine",
      "-",
      "24",
      "-",
      "46",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Dacomitinib",
      "-",
      "0.79",
      "-",
      "11.9",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Dacomitinib",
      "-",
      "1.4",
      "-",
      "4.2",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Dacomitinib",
      "-",
      "0.04",
      "-",
      "9.036",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Disulfiram",
      "-",
      "43",
      "-",
      "16.7",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Disulfiram",
      "-",
      "5.9",
      "-",
      "2.2",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Disulfiram",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Dp44mT",
      "-",
      "0.09",
      "-",
      ">50 ",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Dp44mT",
      "-",
      "1.6",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Dp44mT",
      "-",
      "0.18",
      "-",
      "0.011",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Ebastine",
      "-",
      "1.2",
      "-",
      "13.4",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Ebastine",
      "-",
      "5.45",
      "-",
      "19",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Ebastine",
      "-",
      "1.9",
      "-",
      "13.6",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Ferroquine",
      "-",
      "1.8",
      "-",
      ">10",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Ferroquine",
      "-",
      ">10 ",
      "-",
      ">10",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Ferroquine",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "FK506",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "FK506",
      "-",
      "39.5",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "FK506",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "FRAX486",
      "-",
      "0.006",
      "-",
      "11.5",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "FRAX486",
      "-",
      "1.1",
      "-",
      "0.23",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "FRAX486",
      "-",
      "10.8",
      "-",
      "10.8",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Gatifloxacin",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Gatifloxacin",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Gatifloxacin",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "1.32",
      "-",
      "100",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "0.14",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "39.16",
      "-",
      ">100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Isocyclosporin A",
      "-",
      "0.5",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Isocyclosporin A",
      "-",
      "0.2",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Isocyclosporin A",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Leupeptin Hemisulfate",
      "-",
      "0.03",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Leupeptin Hemisulfate",
      "-",
      "44.9",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Leupeptin Hemisulfate",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "MG-101",
      "-",
      "0.005",
      "-",
      "34.4",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "MG-101",
      "-",
      ">50 ",
      "-",
      "12.9",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "MG-101",
      "-",
      "6.703",
      "-",
      "11.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "MG132",
      "-",
      "0.002",
      "-",
      "2.9",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "MG132",
      "-",
      "0.011",
      "-",
      "0.38",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "MG132",
      "-",
      "0.477",
      "-",
      "0.405",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Nanchangmycin",
      "-",
      "0.01",
      "-",
      "2.97",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Nanchangmycin",
      "-",
      "0.01",
      "-",
      "7.228",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Nanchangmycin",
      "-",
      "0.01",
      "-",
      ">6.66",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Naquotinib",
      "-",
      "0.055",
      "-",
      "79.3",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Naquotinib",
      "-",
      "0.311",
      "-",
      "0.434",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Naquotinib",
      "-",
      "4.85",
      "-",
      "1.228",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "N-Desethylamodiaquine",
      "-",
      "0.4",
      "-",
      ">40",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "N-Desethylamodiaquine",
      "-",
      "2.948",
      "-",
      "40",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "N-Desethylamodiaquine",
      "-",
      "40",
      "-",
      "12.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "NFAT inhibitor",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "NFAT inhibitor",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "NFAT inhibitor",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "NIM811",
      "-",
      "0.09142",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Oxfendazole",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Oxfendazole",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Oxfendazole",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PD0166285",
      "-",
      "0.02",
      "-",
      "78",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PD0166285",
      "-",
      "0.72",
      "-",
      "0.008",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PD0166285",
      "-",
      "6.4",
      "-",
      "0.034",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PF-04691502",
      "-",
      "0.1",
      "-",
      "39",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PF-04691502",
      "-",
      "1.5",
      "-",
      "1.2",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PF-04691502",
      "-",
      "5.5",
      "-",
      "8.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Piperaquine",
      "-",
      "2.1",
      "-",
      ">100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Piperaquine",
      "-",
      ">100 ",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Piperaquine",
      "-",
      ">100 ",
      "-",
      ">100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Primidone",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Primidone",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Primidone",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PSC-833",
      "-",
      "4.8",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PSC-833",
      "-",
      "4.5",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "PSC-833",
      "-",
      "40.85",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Pyronaridine",
      "-",
      "0.18",
      "-",
      "1.798",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Pyronaridine",
      "-",
      "3.204",
      "-",
      "1.696",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Pyronaridine",
      "-",
      "1.396",
      "-",
      "5.048",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.46",
      "-",
      ">40",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.002",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.005",
      "-",
      ">40",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Salinomycin",
      "-",
      "0.17",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Salinomycin",
      "-",
      "0.003",
      "-",
      "30.9",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Salinomycin",
      "-",
      "0.005",
      "-",
      "41.9",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Strontium Ranelate",
      "-",
      "2",
      "-",
      "2",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Strontium Ranelate",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Strontium Ranelate",
      "-",
      ">2",
      "-",
      ">2",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Sulconazole Nitrate",
      "-",
      "50",
      "-",
      "50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Sulconazole Nitrate",
      "-",
      ">50 ",
      "-",
      "16",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Sulconazole Nitrate",
      "-",
      "24.9",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Suplatast Tosilate",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Suplatast Tosilate",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Suplatast Tosilate",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Tetrandrine",
      "-",
      "0.34",
      "-",
      ">2",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Tetrandrine",
      "-",
      "-",
      "-",
      "nd",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Tetrandrine",
      "-",
      ">2",
      "-",
      ">2",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "TMN355",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "TMN355",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "UNC0631",
      "-",
      "0.15",
      "-",
      "28.6",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "UNC0631",
      "-",
      "50",
      "-",
      "50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "UNC0631",
      "-",
      "50",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "WYE-125132",
      "-",
      "0.075",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "WYE-125132",
      "-",
      "0.63",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "WYE-125132",
      "-",
      "0.14",
      "-",
      "39.6",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Y-320",
      "-",
      "0.17",
      "-",
      "26.4",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Y-320",
      "-",
      "0.12",
      "-",
      ">40",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Y-320",
      "-",
      "0.09",
      "-",
      "0.75",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Z-FA-FMK",
      "-",
      "0.014",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Z-FA-FMK",
      "-",
      "0.2",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Z-FA-FMK",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "-",
      "Citicoline",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Pravastatin Sodium",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Tenofovir Alafenamide",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Imatinib Mesylate",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Calcitriol",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Dexlansoprazole",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Prochlorperazine Dimaleate",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "-",
      "Pixatimod",
      "PG545",
      " 2.4 ug/ml",
      "-",
      ">236 ug/ml",
      "Victoria/01/2020",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS",
      "https://doi.org/10.1101/2020.06.24.169334"
    ],
    [
      "-",
      "Pixatimod",
      "PG545",
      " 2.7 ug/ml",
      "-",
      ">236 ug/ml",
      "DE",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS",
      "https://doi.org/10.1101/2020.06.24.169334"
    ],
    [
      "-",
      "Pixatimod",
      "PG545",
      " 8.0 ug/ml",
      "-",
      ">236 ug/ml",
      "QLD02",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS",
      "https://doi.org/10.1101/2020.06.24.169334"
    ],
    [
      "-",
      "Tipiracil",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "A549-hACE2",
      "1",
      "RT-qPCR",
      "CellTracker\u2122 Red",
      "https://doi.org/10.1101/2020.06.26.173872"
    ],
    [
      "-",
      "Berzosertib",
      "-",
      "0.00483",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero-E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "Berzosertib",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "human iPSC cardiomyocytes",
      "-",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "AZD2014",
      "-",
      "0.01593",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "Nilotinib",
      "-",
      "0.08",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "NVP-BHG712",
      "-",
      "0.106",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "YM201636",
      "-",
      "0.06",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "URMC-099",
      "-",
      "0.085",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "AZD8055",
      "-",
      "0.025",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "Torin 2",
      "-",
      "0.00688",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "-",
      "Nitazoxanide+Remdesivir",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Nitazoxanide+Amodiaquine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Nitazoxanide+Umifenovir",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Umifenovir+Mefloquine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Umifenovir+Amodiaquine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Umifenovir+Emetine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Umifenovir+Lopinavir",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "Remdesivir+HydroxyChloroquine",
      "-",
      "-",
      "Antagonistic",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "-",
      "\u03b11-Antitrypsin",
      "-",
      "0.58 mg/ml",
      "-",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.001",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "-",
      "\u03b11-Antitrypsin",
      "-",
      "0.81 mg/ml",
      "-",
      "-",
      "Netherlands/01/NL/2020",
      "Vero E6",
      "0.001",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "-",
      "\u03b11-Antitrypsin",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "human airway epithelial cells (HAECs)",
      "-",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "human airway epithelial cells (HAECs)",
      "-",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "-",
      "DHODHi S312",
      "-",
      "1.55",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "-",
      "DHODHi S416",
      "-",
      "0.017",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "-",
      "Teriflunomide",
      "-",
      "26.06",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "-",
      "Teriflunomide",
      "-",
      "6.001",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.03",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "-",
      "Leflunomide",
      "-",
      "63.56",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "-",
      "Tafenoquine",
      "-",
      "15.7",
      "-",
      "37.2",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by MTT",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.77",
      "-",
      "NT",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by MTT",
      "-",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "-",
      "hydroxyChloroquine",
      "-",
      ">100",
      "-",
      "55.5",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by MTT",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "-",
      "Tafenoquine",
      "-",
      "2.6",
      "-",
      "37.2",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Yield Reduction",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "-",
      "hydroxyChloroquine",
      "-",
      "10.4",
      "-",
      "55.5",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Yield Reduction",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "-",
      "Ethaverine",
      "-",
      ">20",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "NKH477",
      "-",
      ">20",
      "-",
      "7.08",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Trimipramine",
      "-",
      "10",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Osimertinib",
      "-",
      ">20",
      "-",
      "11.22",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Ingenol",
      "-",
      ">20",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Cepharanthine",
      "-",
      "2",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Abemaciclib",
      "-",
      "7.94",
      "-",
      "11.22",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Copanlisib",
      "-",
      ">20",
      "-",
      "0.14",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "-",
      "Chloroquine ",
      "-",
      "4.7",
      "-",
      " >50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Nitazoxanide",
      "-",
      "1",
      "-",
      "3.3",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Ivermectin",
      "-",
      "1.7",
      "-",
      "2.2",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Brequinar",
      "-",
      "0.3",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "U-73343",
      "-",
      "2.7",
      "-",
      "9.6",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "6-Azauridine",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "5-Fluorouracil",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Benztropine",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Bafilomycin A1",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Abiraterone acetate",
      "-",
      "7.1",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Neomycin",
      "-",
      "12.9",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "Hedera helix",
      "-",
      "51 \u00b5g/mL",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "-",
      "oleandrin",
      "-",
      "7.07ng/ml",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero CCL81",
      "0.01",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.15.203489"
    ],
    [
      "-",
      "Famotidine",
      "-",
      ">200",
      "Inactive",
      ">200",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "-",
      "Famotidine",
      "-",
      ">200",
      "Inactive",
      ">200",
      "USA-WA1/2020",
      "A549",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "3.3",
      "-",
      "17.57",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.43",
      "-",
      "14.62",
      "USA-WA1/2020",
      "A549",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "-",
      "Azithromycine",
      "-",
      "2.12",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Omeprazole ",
      "-",
      "17.06",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Oxprenolol hydrochloride",
      "-",
      "20.22",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Hydroxy-Chloroquine ",
      "-",
      "4.17",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Clemizole hydrochloride ",
      "-",
      "23.94",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Alprostadil ",
      "-",
      "5.39",
      "-",
      " >40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Dolutegravir  ",
      "-",
      "22.04",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Sulfadoxine",
      "-",
      "35.37",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Opipramol dihydrochloride",
      "-",
      "5.05",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Quinidine hydrochloride monohydrate",
      "-",
      "5.11",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Arbidol ",
      "-",
      "10.7",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.65\u00b10.79",
      "-",
      "n.d.",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "-",
      "GRL0617",
      "-",
      "~100",
      "-",
      ">100",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.07.17.208959"
    ],
    [
      "-",
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Vero E6",
      "0.1",
      "RT-qPCR/TCID50/Plaque assay",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "-",
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Calu-3",
      "0.5",
      "RT-qPCR/TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "-",
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "NuLi",
      "0.5",
      "TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "-",
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Primary Human Airway Epithelial",
      "0.1",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "-",
      "dimethyl fumarate",
      "DMF",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Vero E6",
      "0.1",
      "RT-qPCR/TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "-",
      "dimethyl fumarate",
      "DMF",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Calu-3",
      "0.5",
      "RT-qPCR/TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "-",
      "Amlodipine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "-",
      "Nifedipine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "-",
      "Felodipine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "-",
      "Verapamil",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "-",
      "Diltiazem",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "-",
      "Diethylenetriaminepentaacetic Acid",
      "DTPA, Pentetic Acid",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "-",
      "VPS34-IN1",
      "-",
      "0.29",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "VPS34-IN1",
      "-",
      "0.55",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "PIKIII",
      "-",
      "0.202",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "PIKIII",
      "-",
      "0.12",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "Orlistat",
      "-",
      "422.3",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "Orlistat",
      "-",
      "21.25",
      "-",
      ">1000",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "Triacsin C",
      "-",
      "19.5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "Triacsin C",
      "-",
      "0.04",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "TC863",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "PF06424439",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "BYL719",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.54",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "-",
      "VIP (Vasoactive intestinal peptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Monocytes",
      "0.01",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "-",
      "VIP (Vasoactive intestinal peptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Calu-3",
      "0.1",
      "Cytopathic effect by Lactate Dehydrogenase",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "-",
      "PACAP (Pituitary adenylate cyclase-activating polypeptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Monocytes",
      "0.01",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "-",
      "PACAP (Pituitary adenylate cyclase-activating polypeptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Calu-3",
      "0.1",
      "Cytopathic effect by Lactate Dehydrogenase",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "-",
      "GC376",
      "-",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI2",
      "-",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI5",
      "-",
      "<5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI6",
      "-",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI10",
      "11a",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI5",
      "-",
      "<5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI7",
      "-",
      "<5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI8",
      "-",
      "<2.5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI5",
      "-",
      "<0.310",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI7",
      "-",
      ">10",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI8",
      "-",
      "<0.310",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI10",
      "11a",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "Pyronaridine",
      "-",
      "1.084/ 2.235",
      "-",
      "37.09",
      "South Korea/KCDC03/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "-",
      "Artesunate",
      "-",
      "53.06/ 23.51",
      "-",
      ">100",
      "South Korea/KCDC03/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "1.069/ 11.19",
      "-",
      "-",
      "South Korea/KCDC03/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "102.9/ 107.8",
      "-",
      "-",
      "South Korea/KCDC03/2020",
      "Calu-3",
      "0.1",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "-",
      "Pyronaridine",
      "-",
      "6.413/8.577",
      "-",
      "43.08",
      "South Korea/KCDC03/2020",
      "Calu-3",
      "0.1",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "-",
      "Artesunate",
      "-",
      "1.76/0.453",
      "-",
      ">100",
      "South Korea/KCDC03/2020",
      "Calu-3",
      "0.1",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "-",
      "MPI1",
      "-",
      ">10",
      "Inactive at 10uM",
      "-",
      "-",
      "Vero E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI3",
      "-",
      ">10",
      "Inactive at 10uM",
      "-",
      "-",
      "Vero E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "MPI4",
      "-",
      ">10",
      "Inactive at 10uM",
      "-",
      "-",
      "Vero E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "-",
      "PTC299",
      "-",
      "0.00196",
      "-",
      ">10",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Quantitative Image Analysis",
      "quantitative image analysis",
      "https://doi.org/10.1101/2020.08.05.238394"
    ],
    [
      "-",
      "Camostat",
      "Camostat mesylate",
      "~0.1",
      "-",
      "-",
      "Germany/FI1103201/2020",
      "Calu-3",
      "0.01/0.001",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.05.237651"
    ],
    [
      "-",
      "FOY-251",
      "-",
      "~0.2",
      "-",
      "-",
      "Germany/FI1103201/2020",
      "Calu-3",
      "0.01/0.001",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.05.237651"
    ],
    [
      "-",
      "NaCl",
      "Hypertonic saline solution",
      "-",
      "Active",
      "-",
      "SP02/human/2020/BRA",
      "Vero CCL-81",
      "-",
      "RT-PCR",
      "AlamarBlue,LDH",
      "https://doi.org/10.1101/2020.08.04.235549"
    ],
    [
      "-",
      "Compound 4",
      "-",
      "3.023",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "XTT Cell Proliferation Assay Kit",
      "https://doi.org/10.1101/2020.08.03.235291"
    ],
    [
      "-",
      "GC376",
      "-",
      "4.481",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "XTT Cell Proliferation Assay Kit",
      "https://doi.org/10.1101/2020.08.03.235291"
    ],
    [
      "-",
      "MAC-5576",
      "-",
      "-",
      "Inactive",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "XTT Cell Proliferation Assay Kit",
      "https://doi.org/10.1101/2020.08.03.235291"
    ],
    [
      "-",
      "Polyman26",
      "-",
      "-",
      "Active",
      "-",
      "-",
      "monocyte-derived dendritic cells=>Vero E6",
      "-",
      "Trans-infection",
      "-",
      "https://doi.org/10.1101/2020.08.09.242917"
    ],
    [
      "-",
      "Tafenoquine",
      "Krintafel, Arakoda, Etaquine, WR 238605, SB-252263",
      "-",
      "Active",
      "-",
      "NTU02 (GenBank:MT066176.1)",
      "Vero E6",
      "0.001",
      "RT-qPCR, Bytopathic Effect",
      "-",
      "https://doi.org/10.1101/2020.08.14.250258"
    ],
    [
      "-",
      "Methylene Blue",
      "-",
      "-",
      "Active",
      "84.72",
      "Switzerland/GE9586/2020",
      "Vero E6",
      "5*106  pfu",
      "Plaque assay",
      "MTS reagent (Promega)",
      "https://doi.org/10.1101/2020.08.14.251090"
    ],
    [
      "-",
      "Clioquinol",
      "5- 31 chloro-7-iodo-8-quinolinol",
      "12.62",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "7-bromo-5- 111 chloro-8-hydroxyquinoline",
      "CLBQ14",
      "14.69",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "5, 7-Dichloro-8-hydroxyquinoline",
      "CLCQ",
      "16.3",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "Aloxistatin",
      "E64d",
      "16.72",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "1.1",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "5.04",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "4.42",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "Calpain Inhibitor IV",
      "-",
      "0.41",
      "-",
      ">7.17",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "-",
      "Maraviroc",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Fingolimod",
      "FTY720",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Nitazoxanide",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Atorvastatin",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Bevacizumab ",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Eculizumab",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "CD126/IL6R antibody",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Pirfenidone   ",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Bromhexine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Dipyridamole",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Ciclesonid",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Indomethacin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Darunavir     ",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Danoprevir",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Arbidol",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Valganciclovir",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Rimantadine",
      "-",
      "-",
      "not active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Letermovir",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      " Baloxavir",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Azithromycin   ",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Tiecoplanin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "-",
      "Azithromycin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "-",
      "Ciprofloxacin",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "-",
      "Ambroxol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "-",
      "Bromhexine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "-",
      "AT-511",
      "Free base form of AT-527",
      "1.8",
      "-",
      ">100",
      "USA-WA1/2020",
      "Human airway epithelial",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.11.242834"
    ],
    [
      "-",
      "AT-511",
      "-",
      "-",
      "Huh-7 cells were not permissive for replication of SARS-CoV-2.",
      ">100",
      "USA-WA1/2020",
      "Huh-7",
      "-",
      "-",
      "-",
      "https://doi.org/10.1101/2020.08.11.242834"
    ],
    [
      "-",
      "Proguanil",
      "-",
      "-",
      "Active",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6, Calu-3",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "-",
      "Sulfasalazine",
      "-",
      "-",
      "Active",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6, Calu-3",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "-",
      "Flucytosine",
      "-",
      "-",
      "Active",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "-",
      "Alogliptin",
      "-",
      "-",
      "Inactive",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "-",
      "Ademetionine",
      "-",
      "-",
      "Inactive",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "-",
      "Mometasone furoate",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "<5.1 (EC90)",
      "-",
      "not toxic",
      "WK-521",
      "Vero E6/TMPRSS2",
      "0.001",
      "Plaque assay",
      "WST reagent",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "<6.0 (EC90)",
      "-",
      "not toxic",
      "WK-521",
      "Calu-3",
      "0.001",
      "Plaque assay",
      "WST reagent",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "<0.55 (EC90)",
      "-",
      "-",
      "WK-521",
      "HBTE/ALI cells",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Nelfinavir",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Lopinavir",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Fluticasone",
      "-",
      "-",
      "Inactive",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Dexamethasone",
      "-",
      "-",
      "Inactive",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "-",
      "Lambda-carrageenan",
      "\u03bb-CGN",
      "0.9 \u00b1 1.1 ug/ml",
      "-",
      ">300.0 \u03bcg/ml",
      "Korea/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.08.23.255364"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "23.5 \u00b1 1.2",
      "-",
      ">300.0",
      "Korea/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.08.23.255364"
    ],
    [
      "-",
      "Remdesivir  ",
      "-",
      "4.6 \u00b1 2.1",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "-",
      "Remdesivir nucleoside",
      "-",
      " 1.7 \u00b1 0.13",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "-",
      "Remdesivir nucleoside, hexadecyloxypropyl-P",
      "HDP-P-RVn",
      "0.96 \u00b1 0.17",
      "-",
      "51",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "-",
      "Remdesivir nucleoside, octadecyloxyethyl-P-",
      "ODE-P-RVn",
      "0.47 \u00b1 0.18",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "-",
      "Remdesivir nucleoside, 1-O-octadecyl-2-\nO-benzyl-glycero-3-P-",
      "ODBG-P-RVn",
      "0.19 \u00b1 0.023",
      "-",
      "46",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.442",
      "-",
      "-",
      "USA-WA1/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "0.221",
      "-",
      "> 10",
      "USA-WA1/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.283",
      "-",
      "-",
      "USA/NYU-VC-003/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "0.184",
      "-",
      "> 10",
      "USA/NYU-VC-003/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "polarized human airway epithelial cultures (HAEC)",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "polarized human airway epithelial cultures (HAEC)",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "-",
      "Prunella vulgaris extract",
      "-",
      "-",
      "Active",
      "-",
      "Canada/ON-VIDO-01/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.28.270306"
    ],
    [
      "-",
      "Suramin",
      "-",
      "-",
      "Active",
      "-",
      "Canada/ON-VIDO-01/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.28.270306"
    ],
    [
      "-",
      "Silicon nitride",
      "Si3N4",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero",
      "-",
      "Plaque assay",
      "CellTiter Glo",
      "https://doi.org/10.1101/2020.08.29.271015"
    ],
    [
      "-",
      "GRL-0496",
      "-",
      "9.12",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.29.272864"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "39.7",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "88.9",
      "-",
      ">100",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "0.23",
      "In the presence of a P-gp efflux inhibitor",
      ">100",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-00835231",
      "-",
      "0.76",
      "In the presence of a P-gp efflux inhibitor",
      ">50",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-07304814",
      "-",
      "87",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-07304814",
      "-",
      "3.8",
      "-",
      ">100",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-07304814",
      "-",
      ">50",
      "In the presence of a P-gp efflux inhibitor",
      ">50",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "PF-07304814",
      "-",
      "0.83",
      "In the presence of a P-gp efflux inhibitor",
      ">50",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "-",
      "Ambroxol Hydrochloride",
      "-",
      ">50",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "Bromhexine Hydrochloride",
      "-",
      "21.72",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "Calpain Inhibitor IV",
      "-",
      "0.29",
      "-",
      ">7.17",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "3.56",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "5.16",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "8.54",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "Aloxistatin",
      "E64d",
      "21.78",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "-",
      "Azelastine-HCl",
      "-",
      "6",
      "-",
      ">25",
      "Hungary/SRC_isolate_2/2020 (Accession ID: EPI_ISL_483637)",
      "Vero E6",
      "0\u00b701",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.15.296228"
    ],
    [
      "-",
      "Azelastine-HCl",
      "-",
      "-",
      "Active",
      "-",
      "Hungary/SRC_isolate_2/2020 (Accession ID: EPI_ISL_483637)",
      "reconstituted human nasal tissue",
      "-",
      "Droplet digitalPCR analysis",
      "-",
      "https://doi.org/10.1101/2020.09.15.296228"
    ],
    [
      "-",
      "ML1000",
      "-",
      "0.1",
      "-",
      ">100",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "-",
      "ML1100",
      "-",
      "0.2",
      "-",
      ">100",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "-",
      "Boceprevir",
      "-",
      "0.2",
      "-",
      "-",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "-",
      "GC-376",
      "-",
      "0.0001",
      "-",
      "-",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "-",
      "Nafamostat",
      "Nafamostat mesylate",
      "-",
      "Active",
      "-",
      "France/IDF0571/2020",
      "3-dimensional human airway epithelia model",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.09.16.300483"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0571/2020",
      "3-dimensional human airway epithelia model",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.09.16.300483"
    ],
    [
      "-",
      "Bromelain",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.09.16.297366"
    ],
    [
      "-",
      "Bafetinib",
      "-",
      "0.79",
      "-",
      ">10",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "Sorafenib",
      "-",
      "1.4",
      "-",
      ">10",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "MLCK inhibitor peptide 18",
      "-",
      "-",
      "Inactive",
      ">10",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "ML-7",
      "-",
      "1.7",
      "-",
      "5",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "Bosutinib",
      "-",
      "0.13",
      "-",
      "0.48",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "Saracatinib",
      "-",
      "0.39",
      "-",
      "0.91",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "Dasatinib",
      "-",
      "1.1",
      "-",
      "0.04",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "-",
      "Nelfinavir+G614 convalescent serum",
      "-",
      "-",
      "Active",
      "-",
      "Norway/Trondheim-S15/2020",
      "\nCalu-3",
      "-",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.17.299933"
    ],
    [
      "-",
      "Nelfinavir+EIDD-2801",
      "-",
      "-",
      "Active",
      "-",
      "Norway/Trondheim-S15/2020",
      "Calu-3",
      "-",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.17.299933"
    ],
    [
      "-",
      "Nelfinavir+Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "Norway/Trondheim-S15/2020",
      "Calu-3",
      "-",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.17.299933"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "3",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.7",
      "-",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Velpatasvir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Elbasvir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Dabrafenib",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Cilostazol",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Nimodipine",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Conivaptan Hydrochloride",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Clobetasol",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Budesonide",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Drosiprenone",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Ezetimibe",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Ivosidenib",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Selexipag",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Meprednisone",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Nifedipine",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Omeprazole Sulfide",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Quinapril",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Rifaximin",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Telmisartan",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Valdecoxib",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Zafirlukast",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Velpatasvir+Sofosbuvir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Remdesivir+Elbasvir+Grazoprevir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "-",
      "Resveratrol",
      "-",
      "66",
      "-",
      ">150",
      "NL/2020",
      "Vero E6",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "-",
      "Pterostilbene",
      "-",
      "19",
      "-",
      ">60",
      "NL/2020",
      "Vero E6",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "-",
      "Resveratrol",
      "-",
      "-",
      "Inactive",
      ">50",
      "NL/2020",
      "Calu-3",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "-",
      "Pterostilbene",
      "-",
      "-",
      "Inactive",
      ">60",
      "NL/2020",
      "Calu-3",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "-",
      "Resveratrol",
      "-",
      "-",
      "Active",
      ">150",
      "NL/2020",
      "Primary human bronchial epithelium cell (PBEC) model",
      "5",
      "Plaque assay\u00a0",
      "LDH/FACS",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "-",
      "Pterostilbene",
      "-",
      "-",
      "Active",
      ">60",
      "NL/2020",
      "Primary human bronchial epithelium cell (PBEC) model",
      "5",
      "Plaque assay\u00a0",
      "LDH/FACS",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "-",
      "Nitazoxanide",
      "[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate",
      "4.9",
      "-",
      ">300",
      "USA-WA1/2020",
      "Vero E6",
      "0.5",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.09.24.312165"
    ],
    [
      "-",
      "JIB-04",
      "5-chloro-N-[(E)-[phenyl(pyridin-2-yl)methylidene]amino]pyridin-2-amine",
      "0.69\u00a0",
      "-",
      ">300",
      "USA-WA1/2020",
      "Vero E6",
      "0.5",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.09.24.312165"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.05",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325316"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.29",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Calu-1",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325316"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.31",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325316"
    ],
    [
      "-",
      "EIDD-2801 ",
      "-",
      "8.5",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325317"
    ],
    [
      "-",
      "EIDD-2801 ",
      "-",
      "2.7",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Calu-1",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325318"
    ],
    [
      "-",
      "EIDD-2801 ",
      "-",
      "1.3",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325319"
    ],
    [
      "-",
      "Galidesivir ",
      "-",
      "48",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325320"
    ],
    [
      "-",
      "Galidesivir ",
      "-",
      "58",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Calu-1",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325321"
    ],
    [
      "-",
      "Galidesivir ",
      "-",
      "24",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325322"
    ],
    [
      "-",
      "Sofosbuvir",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325323"
    ],
    [
      "-",
      "Uprifosbuvir",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325324"
    ],
    [
      "-",
      "Valopicitabine",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325325"
    ],
    [
      "-",
      "Mericitabine",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325326"
    ],
    [
      "-",
      "Ribavirin",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325327"
    ],
    [
      "-",
      "Favipiravir",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325328"
    ],
    [
      "-",
      "Suramin",
      "-",
      "2.9",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Suramin derivative NF023",
      "-",
      "34.1",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Suramin derivative NF110",
      "-",
      "2.87",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Suramin derivative NF157",
      "-",
      "9.52",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Suramin derivative NF279",
      "-",
      "9.26",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Suramin derivative NF449",
      "-",
      "12.99",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Suramin derivative NF546",
      "-",
      "27.4",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.57",
      "-",
      "264",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "-",
      "GNS561",
      "-",
      "0.006",
      "-",
      "2",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "0.1",
      "-",
      "73.23",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.2",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "-",
      "GNS561",
      "-",
      "0.03",
      "-",
      "6.7",
      "IHU-MI3 -MI6",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "-",
      "Auranofin",
      "-",
      "~0.83",
      "-",
      "~2.2",
      "Wuhan/IVDC/-HB -01/2020 (EPI_ISL_402119)",
      "Vero E6",
      "0.015",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.10.16.342097"
    ],
    [
      "-",
      "Gold Cluster",
      "-",
      "~7.32",
      "-",
      ">100",
      "Wuhan/IVDC/-HB -01/2020 (EPI_ISL_402119)",
      "Vero E6",
      "0.015",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.10.16.342097"
    ],
    [
      "-",
      "Itraconazole",
      "-",
      "0.43",
      "-",
      "25.56",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "-",
      "Fluoxetine+Remdesivir",
      "-",
      "-",
      "Synergistic",
      "-",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "-",
      "Itraconazole+Remdesivir",
      "-",
      "-",
      "Synergistic",
      "-",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "-",
      "Itraconazole",
      "-",
      "0.39",
      "-",
      "-",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "ZOX-0000001",
      "Migalastat",
      "DGJ HCl, Migalastat Hydrochloride, Galafold",
      "-",
      "Active",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000009",
      "Entacapone",
      "Comtan",
      "-",
      "Active",
      "232",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000014",
      "Lucerastat",
      "NB-DGJ",
      "-",
      "Active",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000015",
      "Conduritol-B-epoxide",
      "CBE",
      "-",
      "Active",
      ">200",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000016",
      "Miglustat",
      "Zavesca, NB-DNJ",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000017",
      "NN-DNJ",
      "-",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000018",
      "MON-DNJ",
      "UV4, UV4B",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000020",
      "Silmitasertib",
      "CX-4945",
      "-",
      "Active",
      "22.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000021",
      "Dabrafenib mesylate",
      "GSK-2118436",
      "-",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000037",
      "Nafamostat",
      "Nafamostat mesylate, Fusan",
      "-",
      "Active",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000043",
      "Nelfinavir",
      "Nelfinavir mesylate",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000047",
      "Roxadustat",
      "FG4592",
      "-",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000001",
      "Migalastat",
      "DGJ HCl, Migalastat Hydrochloride, Galafold",
      ">1000",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000002",
      "Midostaurin",
      "Rydapt",
      ">1",
      "-",
      "51.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000003",
      "Indomethacin",
      "Indometacin",
      ">100",
      "-",
      "587",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000004",
      "Metformin HCl",
      "Dimethylbiguanid, Fortamet, Glucophage, Glumetza",
      ">100",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000005",
      "Ribavirin",
      "-",
      ">10",
      "-",
      "223",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000006",
      "Mycophenolic Acid",
      "Mycophenolate mofetil",
      ">0.1",
      "-",
      "1.77",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000007",
      "Melatonin",
      "-",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000008",
      "Valproic Acid",
      "Valproat, Depakene, Stavzor, Depacon",
      ">100",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000009",
      "Entacapone",
      "Comtan",
      "-",
      "Active",
      "232",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000010",
      "Verapamil",
      "S-verapamil",
      ">10",
      "-",
      "96.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000011",
      "Haloperidol",
      "Haldol, Serenace",
      ">100",
      "-",
      "271",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000012",
      "(D)-PDMP",
      "N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-decanamide",
      "3.38",
      "Active",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000013",
      "U18666a",
      "-",
      ">0.202",
      "-",
      "7.28",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000014",
      "Lucerastat",
      "NB-DGJ",
      "316",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000015",
      "Conduritol-B-epoxide",
      "CBE",
      ">200",
      "-",
      ">200",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000016",
      "Miglustat",
      "Zavesca, NB-DNJ",
      "170",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000017",
      "NN-DNJ",
      "-",
      "4.63",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000018",
      "MON-DNJ",
      "UV4, UV4B",
      "24.5",
      "Active",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000019",
      "Daunorubicin",
      "Daunorubicin HCl, Acetyladriamycin, Daunomycin, Leukaemomycin C, Rubidomycin",
      ">0.01",
      "-",
      "0.227",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000020",
      "Silmitasertib",
      "CX-4945",
      "<0.771",
      "Active",
      "22.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000021",
      "Dabrafenib mesylate",
      "GSK-2118436",
      "-",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000022",
      "Enisamium",
      "FAV00A, Amizon",
      ">10",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000023",
      "VR17-04",
      "-",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000024",
      "Tamoxifene",
      "Tamoxifen citrate, Nolvadex",
      ">1",
      "-",
      "7.09",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000025",
      "Raloxifene",
      "Raloxifene Hydrochloride, Estiva",
      ">1",
      "-",
      "91.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000026",
      "Atorvastatin",
      "Lipitor, Atorvastatin calcium",
      ">10",
      "-",
      "35.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000027",
      "Tacrolimus",
      "FK-506",
      ">1",
      "-",
      "12.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000028",
      "Clomifene",
      "Clomid, Clomifene citrate, Clomiphene",
      ">1",
      "-",
      "5.76",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000029",
      "Ciprofloxacin",
      "-",
      ">66.7",
      "-",
      "392",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000030",
      "Linezolid",
      "-",
      ">1000",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000031",
      "Lomitapide",
      "Juxtapid, Lojuxta",
      ">1",
      "-",
      "9.26",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000032",
      "Eliglustat",
      "Genz-112638, Cerdelga, Eliglustat tartrate",
      ">10",
      "-",
      "443",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000033",
      "N,N-dimethylamiloride HCl",
      "-",
      ">10",
      "-",
      "92.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000034",
      "Dronedarone",
      "MULTAQ, Dronedarone HCl",
      ">1",
      "-",
      "38.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000035",
      "Tigecycline hydrate",
      "-",
      ">10",
      "-",
      "79.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000036",
      "Rapamycin",
      "Sirolimus, Rapamune",
      ">0.001",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000037",
      "Nafamostat",
      "Nafamostat mesylate, Fusan",
      "2.78",
      "Active",
      "94.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000038",
      "Carmofur",
      "1-hexylcarbamoyl-5-fluorouracil",
      ">0.1",
      "-",
      "67.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000039",
      "Chloramphenicol",
      "Chloramphenicol hydrate",
      ">1000",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000040",
      "Imipramine",
      "Imipramine hydrochloride",
      ">10",
      "-",
      "83",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000041",
      "Amiodarone",
      "Amiodarone HCl",
      ">10",
      "-",
      "28.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000042",
      "Lercanidipine",
      "Lercadip, Lerdip, Zanidip, Lercanidipine HCl",
      ">1",
      "-",
      "13.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000043",
      "Nelfinavir",
      "Nelfinavir mesylate",
      "-",
      "-",
      "41",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000044",
      "BIIB021",
      "CNF2024",
      ">0.01",
      "-",
      "0.348",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000045",
      "Teleglenastat",
      "CB-839",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000046",
      "4EGI-1",
      "-",
      ">1",
      "-",
      "19.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000047",
      "Roxadustat",
      "FG4592",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000048",
      "SR9009",
      "-",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000049",
      "Avasimibe",
      "-",
      ">1",
      "-",
      "9.15",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000050",
      "PT2385",
      "-",
      ">200",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000051",
      "Amiloride hydrochloride",
      "-",
      ">100",
      "-",
      "280",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000052",
      "HMA",
      "5-(N,N-Hexamethylene)amiloride, Hexamethyleneamiloride",
      ">1",
      "-",
      "8.09",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000053",
      "2-Deoxyglucose",
      "-",
      ">100",
      "-",
      "359",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000054",
      "Folic acid",
      "Vitamin B9",
      ">51.5",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000055",
      "MED-COV-4280ac29-15",
      "CVD-0002720",
      ">1",
      "-",
      "16.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000056",
      "SIM-SYN-f15aaa3a-1",
      "CVD-0003482",
      ">1",
      "-",
      "40.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000057",
      "MAT-POS-916a2c5a-1",
      "CVD-0002706",
      ">1",
      "-",
      "42.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000058",
      "MAT-POS-916a2c5a-2",
      "CVD-0002707",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000059",
      "LON-WEI-8f408cad-3",
      "CVD-0001866",
      ">1",
      "-",
      "19.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000060",
      "LON-WEI-adc59df6-47",
      "CVD-0004255",
      ">1",
      "-",
      "38.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000061",
      "MED-COV-4280ac29-31",
      "CVD-0002737",
      ">1",
      "-",
      "7.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000062",
      "5-Thioguanine",
      "Thioguanine, 154-42-7, Tioguanine, 2-Amino-6-mercaptopurine",
      ">1",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000063",
      "Antipain",
      "UNII-47V479BE6L, CCRIS 3605, EINECS 253-631-0",
      ">100",
      "-",
      "50.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000064",
      "Bismuth (III) Subsalicylate",
      "14882-18-9, Bismuth oxysalicylate, Wismutsubsalicylat, Bismuth oxide salicylate",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000065",
      "N-p-Tosyl-L-phenylalanine chloromethyl ketone",
      "TPCK",
      ">1",
      "-",
      "17.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000066",
      "BAY-11 7082 ",
      "BAY 11-7821,19542-67-7,(E)-3-Tosylacrylonitrile, (E)-3-(p-Toluenesulfonyl)acrylonitrile",
      ">1",
      "-",
      "9.59",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000067",
      "Boceprevir",
      "Victrelis, 394730-60-0, SCH 503034, EBP 520",
      "94.2",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000068",
      "Auranofin",
      "2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold, (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate",
      ">1",
      "-",
      "67.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000069",
      "Cisplatin",
      "cis-Diaminedichloroplatinum, cis-Diamminedichlorplatine, cis-Dichlorodiamine platinum, Platinum, diamminedichloro-NCGC00090759-01",
      "92.4",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000070",
      "N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride",
      "TLCK",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000071",
      "IPA 3",
      "Bis(2-hydroxy-1-naphthyl) disulfide, 1,1'-Dithiodi-2-naphthol,UNII-3XFG6MQ9G2",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000072",
      "8-Hydroxy-5-nitroquinoline",
      "Nitroxoline, 5-nitroquinolin-8-ol, 4008-48-4, 5-Nitro-8-hydroxyquinoline",
      ">1",
      "-",
      "70.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000073",
      "NSC95397",
      "93718-83-3, NSC-95397, 2,3-Bis(2-hydroxyethylthio)-1,4-naphthalenedione",
      ">1",
      "-",
      "8.67",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000074",
      "Toremifene",
      "Toremifene citrate, Fareston",
      ">1.67",
      "-",
      "27.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000075",
      "Ruxolitinib",
      "Jafaki ruxolitinib phosphate",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000076",
      "Celecoxib",
      "Celebrex, Onsenal, Elyxyb",
      ">10",
      "-",
      "76.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000077",
      "Alvelestat",
      "-",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000078",
      "Rivaroxiban",
      "Xarelto",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000079",
      "Fludarabine",
      "Fludara, 2-fluoro ARA-A",
      ">1",
      "-",
      "15.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000080",
      "Ambroxol",
      "Mucosolvan, Mucol Brontex",
      ">10",
      "-",
      "45.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000081",
      "Indinavir",
      "IDV, Crixivan",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000082",
      "Itraconazole",
      "-",
      ">1.325",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000085",
      "Olaparib",
      "LYNPARZA, AZD-2281, MK-7339",
      ">1",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000086",
      "PDD00017273",
      "-",
      ">5",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000087",
      "Talazoparib",
      "Talzenna, BMN-673",
      ">0.05",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000088",
      "Veliparib",
      "ABT-888",
      ">5",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000089",
      "NAP-DNJ",
      "-",
      "9.92",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000090",
      "NN-DGJ",
      "-",
      "158",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000091",
      "MON-DGJ",
      "-",
      ">0.25",
      "-",
      "380",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000092",
      "INFa2, Interferon alpha 2",
      "-",
      "<0.001",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000093",
      "INFL4s70, Interferon lambda 4s70",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000094",
      "INFL4p70, Interferon lambda 4p70",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000095",
      "INFL4, Interferon lambda 4",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000096",
      "INFL3, Interferon lambda 3 (Prep 1H)",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000097",
      "INFL3, Interferon lambda 3 (Prep 1)",
      "-",
      "<0.001",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000098",
      "LON-WEI-ff7b210a-4",
      "CVD-0007438",
      ">10",
      "-",
      "89",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000099",
      "LOR-NEU-c8f11034-5",
      "CVD-0005886",
      "15.2",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000100",
      "LON-WEI-babf2c61-1",
      "CVD-0006798",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000101",
      "LOR-NEU-c8f11034-2",
      "CVD-0005883",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000102",
      "TRY-UNI-2eddb1ff-7",
      "CVD-0004754",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000103",
      "ALP-POS-c59291d4-5",
      "CVD-0006354",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000104",
      "ALP-POS-c59291d4-6",
      "CVD-0006355",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000105",
      "ALP-POS-d2866bdf-1",
      "CVD-0007225",
      "15.3",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000106",
      "JOR-UNI-2fc98d0b-12",
      "CVD-0001724",
      "14.9",
      "Active",
      "21.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000107",
      "Sinefungin",
      "Adenosyl-ornithine",
      ">500",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000108",
      "TSF_217",
      "Lactivicin derivative,352",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000109",
      "PLTV",
      "Lactivicin",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000110",
      "BI41",
      "Penicllin sulfone derivate 1",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000111",
      "BI50",
      "Penicllin sulfone derivate 2",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000112",
      "BI71-2",
      "Penicllin sulfone derivate 3",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000113",
      "BI63",
      "Penicllin sulfone derivate 4",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000114",
      "Tenegliptin",
      "Tenelia, Teneligliptin",
      ">47.7",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000115",
      "Ponatinib",
      "Iclusig, AP24534",
      ">10",
      "-",
      "67.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000116",
      "LOR-NOR-30067bb9-7",
      "CVD-0009876",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000117",
      "DAN-LON-a5fc619e-8",
      "CVD-0000654",
      ">10",
      "-",
      "77.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000118",
      "DAN-LON-a5fc619e-3",
      "CVD-0000649",
      ">10",
      "-",
      "79.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000119",
      "LON-WEI-babf2c61-9",
      "CVD-0006806",
      ">10",
      "-",
      "77.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000120",
      "MED-COV-4280ac29-30",
      "CVD-0002736",
      ">10",
      "-",
      "87.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000121",
      "JAN-GHE-5a013bed-2",
      "CVD-0004611",
      ">10",
      "-",
      "104",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000122",
      "EDJ-MED-6af13d92-3",
      "CVD-0005777",
      "15.3",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000123",
      "ADA-UCB-6c2cb422-1",
      "CVD-0007756",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000124",
      "EDJ-MED-6af13d92-1",
      "CVD-0005775",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000125",
      "JAG-UCB-a3ef7265-20",
      "CVD-0005329",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000126",
      "TAT-ENA-80bfd3e5-1; MAT-POS-e10a589d-2",
      "CVD-0008035",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000127",
      "MAT-POS-e10a589d-1",
      "CVD-0012923",
      ">1",
      "-",
      "8.97",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000128",
      "PAU-UNI-8cdd41c7-1",
      "CVD-0003037",
      ">10",
      "-",
      "32.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000129",
      "LON-WEI-2e27a2e5-1",
      "CVD-0010542",
      ">10",
      "-",
      "81.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000130",
      "TRY-UNI-714a760b-3",
      "CVD-0003629",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000131",
      "AGN-NEW-891393a6-1",
      "CVD-0000033",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000132",
      "ALP-POS-c59291d4-2",
      "CVD-0006351",
      "31.5",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000133",
      "ALP-POS-91609ae9-3",
      "CVD-0006189",
      ">10",
      "-",
      "86.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000134",
      "DAV-CRI-14a23e73-1",
      "CVD-0000864",
      ">10",
      "-",
      "81.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000135",
      "BEN-DND-93268d01-8",
      "CVD-0005075",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000136",
      "BOLD100",
      "-",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000137",
      "Alendronate",
      "Fosamax, Alendronic Acid, Alendronate Sodium, Binosto",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000138",
      "Clodronate",
      "Clodronic Acid, Sodium Clodronate",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000139",
      "Zolendronate",
      "Zoledronic Acid, Zometa, Reclast",
      ">1",
      "-",
      "29.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000140",
      "Ox14",
      "1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)-ethyl-bisphosphonate",
      ">1",
      "-",
      "16",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000141",
      "Azetronam",
      "IAL-MD0005",
      ">50",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000142",
      "IAL-MD0128",
      "24218528",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000143",
      "IAL-MD0131",
      "40017795",
      ">50",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000144",
      "Quercetin",
      "Sophoretin; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one ",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000145",
      "ALP-POS-3b848b35-2",
      "CVD-0010545",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000146",
      "VLA-UCB-1dbca3b4-15",
      "CVD-0012801",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000147",
      "Activin A",
      "-",
      ">33",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000148",
      "EDJ-MED-c314995a-1",
      "CVD-0011943",
      ">10",
      "-",
      "12.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000149",
      "MAT-POS-11b63608-1",
      "CVD-0013197",
      ">10",
      "-",
      "26",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000150",
      "MAT-POS-9ff17035-3",
      "CVD-0012742",
      ">1",
      "-",
      "2.08",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000151",
      "MAT-POS-bbbbc21a-3",
      "CVD-0013195",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000152",
      "MAT-POS-f2460aef-3",
      "CVD-0013166",
      ">10",
      "-",
      "79.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000153",
      "MAT-POS-f2460aef-4",
      "CVD-0013167",
      ">1",
      "-",
      "9.79",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000154",
      "MAT-POS-f7918075-2",
      "CVD-0012962",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000155",
      "MAT-POS-fa06b69f-6",
      "CVD-0013057",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000156",
      "PET-UNK-1901c25b-1",
      "CVD-0013216",
      ">1",
      "-",
      "24.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000157",
      "EDJ-MED-00c1612e-1",
      "CVD-0010618",
      ">1",
      "-",
      "4.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000158",
      "MAT-POS-b3e365b9-1",
      "CVD-0013192",
      "1.99",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000159",
      "MAT-POS-f2460aef-1",
      "CVD-0013164",
      "2.89",
      "-",
      "14.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000160",
      "ALP-POS-c59291d4-1",
      "CVD-0006350",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000161",
      "MAT-POS-3b92565d-1",
      "CVD-0011616",
      ">10",
      "-",
      "13.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000162",
      "ERI-UCB-ce40166b-17",
      "CVD-0007597",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000163",
      "Clofazimine",
      "Lamprene",
      ">1",
      "-",
      "39.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000164",
      "Niclosamide",
      "5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide",
      ">1",
      "-",
      "3.05",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000165",
      "Favipiravir",
      "6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000166",
      "Merimepodib",
      "-",
      ">1",
      "-",
      "1.02",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000167",
      "Nitazoxanide",
      "Alinia",
      ">1",
      "-",
      "1.57",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000168",
      "Daclatasvir",
      "Daklinza",
      ">10",
      "-",
      "34",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000169",
      "Camostate",
      "Camostat",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000170",
      "MAT-POS-8a69d52e-2",
      "CVD-0013291",
      "1.82",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000171",
      "EDJ-MED-e4b030d8-2",
      "CVD-0013199",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000172",
      "JOH-MSK-46727e7b-1",
      "CVD-0013146",
      "3.67",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000173",
      "LON-WEI-5e7d1b3e-72",
      "CVD-0010838",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000174",
      "LON-WEI-5e7d1b3e-68",
      "CVD-0010835",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000175",
      "ALP-POS-6d04362c-2",
      "CVD-0012949",
      "3.76",
      "-",
      "79",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000176",
      "MAT-POS-54c4bf04-3",
      "CVD-0014251",
      ">10",
      "-",
      "72.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000177",
      "JOH-UNI-ea1df7a8-1",
      "CVD-0014244",
      ">1",
      "-",
      "27.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000178",
      "MAT-POS-8d5af1ef-1",
      "CVD-0014153",
      "23",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000179",
      "MAT-POS-3b536971-1",
      "CVD-0014247",
      "7.9",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000180",
      "ALP-POS-696356e4-1",
      "CVD-0014383",
      "3.23",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000181",
      "MAT-POS-53907a1c-3",
      "CVD-0013693",
      ">10",
      "-",
      "81.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000182",
      "MAT-POS-23a8a11a-1",
      "CVD-0014468",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000183",
      "PET-UNK-c9c1e0d8-3",
      "CVD-0011629",
      "8.97",
      "-",
      "77",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000184",
      "VLA-UCB-29506327-1",
      "CVD-0014471",
      ">1",
      "-",
      "70.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000185",
      "MAT-POS-0c8fa4a7-1",
      "CVD-0013694",
      "9.08",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000186",
      "ALP-POS-477dc5b7-1",
      "CVD-0013211",
      "6.88",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000187",
      "ALP-POS-477dc5b7-2",
      "CVD-0013212",
      "2.19",
      "-",
      "68.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000188",
      "MAT-POS-8a69d52e-6",
      "CVD-0013295",
      "0.915",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000189",
      "EDJ-MED-e4b030d8-13",
      "CVD-0013210",
      "1.67",
      "-",
      "74.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000190",
      "PET-UNK-c9c1e0d8-4",
      "CVD-0011630",
      "3.57",
      "-",
      "74.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000191",
      "RBN-2397",
      "Atamparib",
      ">3.3",
      "-",
      "86.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000192",
      "RBN012759",
      "7-(cyclopropylmethoxy)-5-fluoro-2-{[(trans-4-hydroxycyclohexyl)sulfanyl]methyl}quinazolin-4(3H)-one",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000193",
      "ALP-POS-966f8da6-2",
      "CVD-0014245",
      ">33.3",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000194",
      "MAT-POS-090737b9-1",
      "CVD-0015227",
      "2.8",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000195",
      "rel-EDJ-MED-12c115cc-1",
      "CVD-0014914",
      ">1",
      "-",
      "14.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000196",
      "RAL-THA-4aa06b95-1",
      "CVD-0014255",
      "35.1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000197",
      "MAT-POS-6c284e65-1",
      "CVD-0015011",
      "3.01",
      "-",
      "57.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000198",
      "rac-PET-UNK-29afea89-2",
      "CVD-0015328",
      "1.01",
      "-",
      "104",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000199",
      "BRU-THA-92256091-17",
      "CVD-0014292",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000200",
      "MIC-UNK-91acba05-6",
      "CVD-0013559",
      ">1",
      "-",
      "37",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000201",
      "ALP-POS-ce760d3f-1",
      "CVD-0014502",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000202",
      "RAL-THA-2d450e86-17",
      "CVD-0015041",
      "2.89",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000203",
      "RAL-THA-2d450e86-16",
      "CVD-0015040",
      "3.32",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000204",
      "RAL-THA-2d450e86-14",
      "CVD-0015038",
      "3.03",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000205",
      "ALP-POS-869ac754-1",
      "CVD-0015012",
      "1.01",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000206",
      "BEN-DND-c852c98b-5",
      "CVD-0014233",
      "9.27",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000207",
      "RAL-THA-8416115c-6",
      "CVD-0014266",
      "5.91",
      "-",
      "41.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000208",
      "RAL-THA-2d450e86-6",
      "CVD-0015030",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000209",
      "ALP-UNI-3735e77e-2",
      "CVD-0015022",
      "3.19",
      "-",
      "> 87.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000210",
      "ALP-POS-d91e0300-1",
      "CVD-0015066",
      "1.01",
      "-",
      "74.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000211",
      "rel-PET-UNK-29afea89-2",
      "CVD-0013943",
      "0.241",
      "-",
      "59.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000212",
      "rel-EDJ-MED-92e193ae-1",
      "CVD-0014805",
      "0.995",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000213",
      "T-5224",
      "3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000214",
      "ALP-POS-c3a96089-4",
      "CVD-0014210",
      "5.52",
      "-",
      "22.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000215",
      "VLA-UCB-50c39ae8-7",
      "CVD-0013309",
      "8.47",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000216",
      "ALP-UNI-3735e77e-4",
      "CVD-0015024",
      "0.856",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000217",
      "BEN-BAS-c2bc0d80-6",
      "CVD-0014160",
      "1.04",
      "-",
      "49.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000218",
      "MAT-POS-3b97339c-2",
      "CVD-0016321",
      "0.843",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000219",
      "MAT-POS-e69ad64a-2",
      "CVD-0015332",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000220",
      "EDJ-MED-d08626de-3",
      "CVD-0015340",
      ">0.1",
      "-",
      "13.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000221",
      "EDJ-MED-37aac4bd-4",
      "CVD-0015861",
      ">0.1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000222",
      "MAT-POS-a13804f0-3",
      "CVD-0016447",
      "1.04",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000223",
      "MAT-POS-f9802937-8",
      "CVD-0015381",
      "0.843",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000224",
      "MAT-POS-a13804f0-4",
      "CVD-0016448",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000225",
      "ALP-POS-fe871b40-11",
      "CVD-0015853",
      "1.11",
      "-",
      "24.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000226",
      "MAT-POS-78e1d523-1",
      "CVD-0016254",
      "2.2",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000227",
      "MAT-POS-932d1078-3",
      "CVD-0016505",
      "0.152",
      "-",
      "37.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000228",
      "Remdesivir",
      "CVD-0016508",
      "0.549",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000229",
      "Molnupiravir",
      "CVD-0016509",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000230",
      "MAT-POS-3ccb8ef6-1",
      "CVD-0016619",
      "2.99",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000231",
      "BEN-BAS-c2bc0d80-7",
      "CVD-0014161",
      "1.79",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000232",
      "EDJ-MED-9e38fd34-1",
      "CVD-0015343",
      "2.92",
      "-",
      "44.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000233",
      "EDG-MED-ba1ac7b9-9",
      "CVD-0015596",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000234",
      "EDG-MED-5d232de5-5",
      "CVD-0015362",
      "2.47",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000235",
      "JNK-IN-8",
      "(E)-3-(4-(dimethylamino)but-2-enamido)-N-(3-methyl-4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide",
      ">1",
      "-",
      "1.53",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000236",
      "LY3214996",
      "6,6-dimethyl-2-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-5-(2-morpholinoethyl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one",
      ">10",
      "-",
      "86",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000237",
      "ALP-POS-477dc5b7-5",
      "CVD-0013215",
      "2.83",
      "-",
      "94.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000238",
      "MAT-POS-96f51285-6",
      "CVD-0016875",
      ">0.03",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000239",
      "ALP-UNI-8d415491-5",
      "CVD-0016486",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000240",
      "MAT-POS-a5ef2d74-2",
      "CVD-0016992",
      "1.95",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000241",
      "MAT-POS-dd3ad2b5-3",
      "CVD-0016467",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000242",
      "ALP-UNI-8d415491-2",
      "CVD-0016483",
      "4.17",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000243",
      "MIC-UNK-91acba05-3",
      "CVD-0013558",
      "3.52",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000244",
      "MAT-POS-96f51285-1",
      "CVD-0016870",
      "1.35",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000245",
      "JIN-POS-6dc588a4-22",
      "CVD-0016572",
      ">0.33",
      "-",
      "43.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000246",
      "MAT-POS-dd3ad2b5-4",
      "CVD-0016468",
      "3.64",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000247",
      "MAT-POS-96f51285-2",
      "CVD-0016871",
      "3.14",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000248",
      "MAT-POS-dd3ad2b5-5",
      "CVD-0016469",
      "7.91",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000249",
      "MAT-POS-96f51285-3",
      "CVD-0016872",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000250",
      "MAT-POS-dd3ad2b5-2",
      "CVD-0016466",
      "4.6",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000251",
      "MAT-POS-96f51285-5",
      "CVD-0016874",
      "4.04",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000252",
      "MAT-POS-993cdc78-1",
      "CVD-0016690",
      "1.02",
      "-",
      "77.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000253",
      "ALP-UNI-8d415491-6",
      "CVD-0016487",
      "3.26",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000254",
      "ALP-POS-fe871b40-16",
      "CVD-0015858",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000255",
      "MAT-POS-4223bc15-4",
      "CVD-0016899",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000256",
      "MAT-POS-4223bc15-25",
      "CVD-0016918",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000257",
      "EDJ-MED-611d11e7-4",
      "CVD-0016452",
      "-",
      "-",
      "40.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000258",
      "MAT-POS-4223bc15-6",
      "CVD-0016901",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000259",
      "MAT-POS-4223bc15-23",
      "CVD-0016916",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000260",
      "MAT-POS-ec6d90b7-6",
      "CVD-0017144",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000261",
      "MAT-POS-4223bc15-11",
      "CVD-0016906",
      "-",
      "-",
      "91.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000262",
      "MAT-POS-4223bc15-9",
      "CVD-0017253",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000263",
      "MAT-POS-4223bc15-2",
      "CVD-0016897",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000264",
      "MAT-POS-4223bc15-12",
      "CVD-0016907",
      "-",
      "-",
      "94.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000265",
      "MIC-UNK-91acba05-1",
      "CVD-0013556",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000266",
      "MAT-POS-4223bc15-3",
      "CVD-0016898",
      "-",
      "-",
      "> 82.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000267",
      "MAT-POS-4223bc15-31",
      "CVD-0016924",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000268",
      "RAL-THA-6e4c80cf-1",
      "CVD-0016844",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000269",
      "MAT-POS-4223bc15-41",
      "CVD-0016934",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000270",
      "MAT-POS-4223bc15-18",
      "CVD-0016913",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000271",
      "MAT-POS-4223bc15-40",
      "CVD-0016933",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000272",
      "MAT-POS-4223bc15-1",
      "CVD-0016896",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ZOX-0000273",
      "MAT-POS-4223bc15-39",
      "CVD-0016932",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "-",
      "P7 SALEE QYKTF LDKFL HELED LLYQL ALAL-NH2",
      "-",
      "7 / 6.8",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "-",
      "P8 SALEE QLKTF LDKFM HELED LLYQL AL-NH2",
      "-",
      "0.8 / 0.09",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "-",
      "P9 SALEE QYKTF LDKFM HELED LLYQL SL-NH2",
      "-",
      "0.3 / 0.07",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "-",
      "P10 SALEE QYKTF LDKFM HELED LLYQL AL-NH2",
      "-",
      "0.06 / 0.08",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "-",
      "AHB1",
      "-",
      "0.035",
      "-",
      "-",
      "SARS-CoV-2 strain 2019 n-CoV/USA_WA1/2020",
      "Vero E6",
      "100 FFU",
      "Immunoimaging ",
      "-",
      "https://doi.org/10.1101/2020.08.03.234914"
    ],
    [
      "-",
      "LCB1",
      "-",
      "34.46pM",
      "-",
      "-",
      "SARS-CoV-2 strain 2019 n-CoV/USA_WA1/2020",
      "Vero E6",
      "100 FFU",
      "Immunoimaging ",
      "-",
      "https://doi.org/10.1101/2020.08.03.234914"
    ],
    [
      "-",
      "LCB3",
      "-",
      "48.1pM",
      "-",
      "-",
      "SARS-CoV-2 strain 2019 n-CoV/USA_WA1/2020",
      "Vero E6",
      "100 FFU",
      "Immunoimaging ",
      "-",
      "https://doi.org/10.1101/2020.08.03.234914"
    ],
    [
      "-",
      "ACIS KEpTide\u2122",
      "-",
      "-",
      "active",
      "-",
      "Vero E6",
      "SARS-CoV2 (SARS CoV-2 USA_WA1/2020)",
      "01/fev",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.13.337584"
    ],
    [
      "-",
      "merafloxacin",
      "CI-934",
      "2.6",
      "-",
      "not toxic",
      "Vero E6",
      "SARS-CoV-2",
      "5",
      "Plaque assay",
      "ATP prod/ LDH",
      "https://doi.org/10.1101/2020.10.21.349225"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "-",
      "active",
      "-",
      "Primary nHTBE",
      "SARS-CoV-2 strain 2019-nCoV/USA_WA1/2020",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2020.10.19.343954"
    ],
    [
      "-",
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "0.074",
      "-",
      "-",
      "Vero E6",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "Cytopathic effect",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "-",
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "<0.080",
      "-",
      "-",
      "A549/ACE2",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "Cytopathic effect",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "-",
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "0.004",
      "-",
      "-",
      "HeLa/ACE2",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "Cytopathic effect",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "-",
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "5.5",
      "-",
      "-",
      "Calu-3",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "1",
      "Immunofluorescence",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "-",
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "4.3",
      "-",
      "-",
      "Caco-2",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "-",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "-",
      "GS-441524",
      "parent nucleotide of Remdesivir",
      "0.7",
      "-",
      ">50",
      "Vero E6",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "CCK8",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "-",
      "GS-441524",
      "parent nucleotide of Remdesivir",
      "3.21",
      "-",
      ">50",
      "calu-3",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "CCK8",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "-",
      "GS-441524",
      "parent nucleotide of Remdesivir",
      "3.62",
      "-",
      ">50",
      "caco-2",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "CCK8",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.35",
      "-",
      "-",
      "Vero E6",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.65",
      "-",
      "-",
      "calu-3",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.58",
      "-",
      "-",
      "caco-2",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "-",
      "Simeprevir ",
      "-",
      "1.40 \u00b1 0.09",
      "-",
      "18.58",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "Cinacalcet ",
      "-",
      "2.93 \u00b1 0.38",
      "-",
      "21.23",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "Ethacridine  ",
      "-",
      "0.08\u00b1 0.01",
      "-",
      ">40",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "ABT-199 (Venetoclax) ",
      "Venetoclax",
      "1.18 \u00b1 0.12",
      "-",
      "20.56",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "Hydroxyprogesterone Cell viability (%) EC50 = 2.77 \u00b1 0.49 \"M CC50 ",
      "-",
      "2.77 \u00b1 0.49",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "Remdesivir ",
      "-",
      "0.52 \u00b1 0.09",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "Ethacridine  ",
      "-",
      "-",
      "active",
      "-",
      "primary human nasal epithelial cells",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "Ethacridine  ",
      "-",
      "-",
      "active",
      "-",
      "A549",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "-",
      "5-amino levulinic acid",
      "5-ALA",
      "570",
      "-",
      "-",
      "VeroE6",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.002",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "-",
      "5-amino levulinic acid/Sodium ferrous citrate",
      "5-ALA/SFC",
      "695",
      "-",
      "-",
      "VeroE6",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.002",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "-",
      "5-amino levulinic acid",
      "5-ALA",
      "39",
      "-",
      "-",
      "Caco-2",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.02",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "-",
      "5-amino levulinic acid/Sodium ferrous citrate",
      "5-ALA/SFC",
      "63",
      "-",
      "-",
      "Caco-2",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.02",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "-",
      "Maduramycin",
      "-",
      "0.078",
      "-",
      "31",
      "Vero E6",
      "SARS-CoV-2 (IVCAS 6.7512)",
      "0.05",
      "qRT-PCR",
      "CCK-8 assays",
      "https://doi.org/10.1101/2020.10.27.354563"
    ],
    [
      "-",
      "CP-80,219",
      "-",
      "0.009",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2 (IVCAS 6.7512)",
      "0.05",
      "qRT-PCR",
      "CCK-8 assays",
      "https://doi.org/10.1101/2020.10.27.354563"
    ],
    [
      "-",
      "Brilacidin",
      "-",
      "~10",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.1",
      "Plaque assay",
      "CellTitreGlo",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "-",
      "Brilacidin",
      "-",
      "0.565",
      "-",
      "241",
      "calu-3",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.05",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "-",
      "Brilacidin/favipiravir",
      "-",
      "-",
      "not synergistic inhibition",
      "-",
      "calu-3",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.05",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "-",
      "Brilacidin/Remdesivir",
      "-",
      "-",
      "synergistic inhibition",
      "-",
      "calu-3",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.05",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "-",
      "GSK717",
      "-",
      "-",
      "active",
      "-",
      "-",
      "ACE2-SK-N-SH (neuroblastoma)",
      "0.05-5",
      "Plaque assay",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.11.05.370767"
    ],
    [
      "-",
      "GSK583",
      "-",
      "-",
      "active",
      "-",
      "-",
      "ACE2-SK-N-SH (neuroblastoma)",
      "0.05-5",
      "Plaque assay, qRT-PCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.11.05.370767"
    ],
    [
      "-",
      "GSK583",
      "-",
      "-",
      "active",
      "-",
      "-",
      "Calu-3, Huh7",
      "-",
      "Plaque assay",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.11.05.370767"
    ],
    [
      "-",
      "Thymol",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "-",
      "Carvacrol",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "-",
      "Hesperidin",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "-",
      "Thymoquinone",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "-",
      "Ponatinib ",
      "-",
      "1.1\u00b1 0.2 ",
      "-",
      "8.7 \u00b1 3.8",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Carbenoxolone",
      "-",
      " 66 \u00b111 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Lurasidone ",
      "-",
      "18.0 \u00b1 4.6 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Elbasvir ",
      "-",
      "23.0 \u00b1 3.6 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Teniposide ",
      "-",
      "97.0 \u00b1 0.7",
      "-",
      " >100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Venetoclax  ",
      "-",
      "6.2 \u00b1 0.6",
      "-",
      "22.0\u00b1 6.2",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Irinotecan ",
      "-",
      "85.2 \u00b1 17.0 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Simeprevir ",
      "-",
      "9.3 \u00b1 2.0 ",
      "-",
      "47.5 \u00b1 41.0",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Grazoprevir ",
      "-",
      "16.0 \u00b1 5.7",
      "-",
      " >100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Natamycin  ",
      "-",
      "24.3 \u00b1 4.4",
      "-",
      "35.9\u00b1 13.4",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Suramin  ",
      "-",
      "64.0\u00b1 6.6",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "-",
      "Stenoparib",
      "-",
      "-",
      "active",
      ">60uM",
      "SARS-CoV-2 (USA-WA1/2020)",
      "Calu-3",
      "0.04",
      "RT-qPCR, Plaque assay",
      "CytoTox 96\u2122",
      "https://doi.org/10.1101/2020.11.12.380394"
    ],
    [
      "-",
      "Stenoparib",
      "-",
      "-",
      "-",
      "toxic",
      "SARS-CoV-2 (USA-WA1/2020)",
      "Vero E6",
      "-",
      "-",
      "CytoTox 96\u2122",
      "https://doi.org/10.1101/2020.11.12.380394"
    ],
    [
      "-",
      "Itraconazole",
      "-",
      "2.3",
      "-",
      ">50",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "0.01",
      "MTT",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "-",
      "Itraconazole",
      "-",
      "1.5",
      "-",
      "-",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "-",
      "CPE visual read-out",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "-",
      "Itraconazole,-17-OH",
      "-",
      "3.6",
      "-",
      ">100",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "0.01",
      "MTT",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "-",
      "Itraconazole,-17-OH",
      "-",
      "1.2",
      "-",
      "-",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "-",
      "CPE visual read-out",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "-",
      "Rhodomyrtone",
      "-",
      "0.44",
      "-",
      "-",
      "SARS-CoV-2/Guangdong/20SF014",
      "Vero E6",
      "-",
      "CPE ",
      "-",
      "https://doi.org/10.1101/2020.11.14.382770"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.72",
      "-",
      "-",
      "SARS-CoV-2/Guangdong/20SF014",
      "Vero E6",
      "-",
      "CPE ",
      "-",
      "https://doi.org/10.1101/2020.11.14.382770"
    ],
    [
      "-",
      "Hypothiocyanite",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (Genbank: MW000351)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTT Cell 335 Proliferation Assay",
      "https://doi.org/10.1101/2020.11.17.387571"
    ],
    [
      "-",
      "Hypothiocyanite/lactoferrin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (Genbank: MW000351)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTT Cell 335 Proliferation Assay",
      "https://doi.org/10.1101/2020.11.17.387571"
    ],
    [
      "-",
      "Imatinib",
      "-",
      "2.5",
      "-",
      ">40",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "-",
      "Masitinib",
      "-",
      "2.3",
      "-",
      "26.3",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "-",
      "Asciminib",
      "-",
      "19.6",
      "-",
      "21.7",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.2",
      "-",
      ">20",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "-",
      "Imatinib",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain BavPat1",
      "bronchial epithelium",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "-",
      "PolyP120",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 viral particles Italian patient",
      "Vero E6, Caco2 and human primary nasal epithelial cells",
      "-",
      "RT-qPCR,Immunoblotting",
      "-",
      "https://doi.org/10.1101/2020.11.18.388413"
    ],
    [
      "-",
      "Mefloquine",
      "-",
      "1.28",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "1.94",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "-",
      "Primaquine",
      "-",
      "2.47",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "-",
      "Quinine",
      "-",
      "14.9",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "-",
      "Quinidine",
      "-",
      "3.68",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "-",
      "CR-31-B (-)",
      "-",
      "~0.018",
      "-",
      ">0.1",
      "SARS-CoV-2",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "-",
      "CR-31-B (-)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "human bronchial epithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "-",
      "Silvestrol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "human bronchial epithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "-",
      "CR-31-B (+)",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2",
      "human bronchial epithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "-",
      "Niclosamide ",
      "-",
      "1.1",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Penfluridol ",
      "-",
      "2.6",
      "-",
      "19",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Digoxin  ",
      "-",
      "0.6",
      "-",
      "55",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Metergoline  ",
      "-",
      "3.7",
      "-",
      "40",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Imatinib ",
      "-",
      "5",
      "-",
      "91",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Efloxate ",
      "-",
      "12.7",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Ebastine  ",
      "-",
      "5.2",
      "-",
      "45",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Protoporphyrin IX ",
      "-",
      "0.1",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Mycophenolate mofetil  ",
      "-",
      "3.6",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Pimozide  ",
      "-",
      "3.9",
      "-",
      "21",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Lanatoside C  ",
      "-",
      "0.1",
      "-",
      "80",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Cepharantine  ",
      "-",
      "1",
      "-",
      "20",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Clofazimine  ",
      "-",
      "2.8",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Remdesivir   ",
      "-",
      "1.6",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "-",
      "Nitazoxanide, Ribavirin, and HydroxyChloroquine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/WA/20/01",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.399055"
    ],
    [
      "-",
      "Lapatinib",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate, Hong Kong/VM20001061/2020",
      "MRC5-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.398859"
    ],
    [
      "-",
      "17-AAG",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate, Hong Kong/VM20001061/2020",
      "MRC5-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.398859"
    ],
    [
      "-",
      "Doramapimod",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate, Hong Kong/VM20001061/2020",
      "MRC5-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.398859"
    ],
    [
      "-",
      "Emetine",
      "-",
      "0.000147",
      "-",
      "1.6038",
      "SARS-CoV-2 (Accession Number VTCCAVA294)",
      "Vero",
      "-",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.29.401984"
    ],
    [
      "-",
      "Boceprevir  ",
      "-",
      "44",
      "-",
      "> 1214",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Telaprevir ",
      "-",
      "40",
      "-",
      "> 432",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Narlaprevir  ",
      "-",
      "37",
      "-",
      "269",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Simeprevir  ",
      "-",
      "15",
      "-",
      "59",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Paritaprevir  ",
      "-",
      "22",
      "-",
      "123",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Grazoprevir  ",
      "-",
      "42",
      "-",
      "239",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Glecaprevir ",
      "-",
      "> 178 ",
      "-",
      "> 268",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Voxilaprevir  ",
      "-",
      "> 41",
      "-",
      "72",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Vaniprevir  ",
      "-",
      "51",
      "-",
      "171",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Danoprevir  ",
      "-",
      "87",
      "-",
      "> 243",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Deldeprevir  ",
      "-",
      "> 20",
      "-",
      "56",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Asunaprevir  ",
      "-",
      "72",
      "-",
      "263",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Faldapreir ",
      "-",
      "23",
      "-",
      "246",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "ACH-806  ",
      "-",
      "46",
      "-",
      "> 429",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Boceprevir  ",
      "-",
      "21",
      "-",
      "701",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Simeprevir  ",
      "-",
      "14",
      "-",
      "33",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Grazoprevir  ",
      "-",
      "20",
      "-",
      "133",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "-",
      "Pyronaridine",
      "-",
      "0.198",
      "-",
      "-",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Quinacrine",
      "-",
      "0.122",
      "-",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Tilorone",
      "-",
      "0.18",
      "-",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.147",
      "-",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Quinacrine hydrochloride",
      "-",
      "> 7.33 ",
      "-",
      "7.33",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Tilorone dihydrochloride",
      "-",
      "6.62",
      "-",
      "49.64",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Pyronaridine tetraphosphate",
      "-",
      "> 3.52 ",
      "-",
      "3.52",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Quinacrine hydrochloride",
      "-",
      "10.54",
      "-",
      "229.15",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Tilorone dihydrochloride",
      "-",
      "28.96",
      "-",
      "111.49",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Pyronaridine tetraphosphate",
      "-",
      "5.49",
      "-",
      "51.65",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Tilorone dihydrochloride",
      "-",
      "10.77",
      "-",
      "19.87",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Pyronaridine tetraphosphate",
      "-",
      ">50",
      "-",
      "6.49",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "Quinacrine hydrochloride",
      "-",
      ">50",
      "-",
      "7.63",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "-",
      "GC376",
      "-",
      "1.51",
      "-",
      "> 125",
      "SARS-CoV-2 (USA-WA1/2020 isolate)",
      "Vero E6",
      "-",
      "Immunofluorescence assay",
      "-",
      "https://doi.org/10.1101/2020.12.19.423537"
    ],
    [
      "-",
      "23R",
      "-",
      "1.27",
      "-",
      "> 78.7",
      "SARS-CoV-2 (USA-WA1/2020 isolate)",
      "Vero E6",
      "-",
      "Immunofluorescence assay",
      "-",
      "https://doi.org/10.1101/2020.12.19.423537"
    ],
    [
      "-",
      "23R",
      "-",
      "3.03",
      "-",
      ">100",
      "SARS-CoV-2 (USA-WA1/2020 isolate)",
      "Calu-3",
      "-",
      "Immunofluorescence assay",
      "-",
      "https://doi.org/10.1101/2020.12.19.423537"
    ],
    [
      "-",
      "Glycyrrhizin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "-",
      "Plaque assay, RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.12.18.423104"
    ],
    [
      "-",
      "Ivermectin",
      "-",
      "2.3",
      "-",
      "-",
      "SARS-CoV-2/Human/Liverpool/REMRQ0001/2020",
      "VERO E6",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.23.424232"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.9",
      "-",
      "-",
      "SARS-CoV-2/Human/Liverpool/REMRQ0001/2020",
      "VERO E6",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.23.424232"
    ],
    [
      "-",
      "Ivermectin+Remdesivir",
      "-",
      "-",
      "synergistic interaction",
      "-",
      "SARS-CoV-2/Human/Liverpool/REMRQ0001/2020",
      "VERO E6",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.23.424232"
    ],
    [
      "-",
      "Gallinamide A analogue 19",
      "-",
      "0.168",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "-",
      "Gallinamide A analogue 23",
      "-",
      "0.92",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "-",
      "Gallinamide A analogue 17",
      "-",
      "6.07",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "-",
      "Gallinamide A analogue 20",
      "-",
      ">5",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "-",
      "Gallinamide A",
      "-",
      "0.028",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "-",
      "Berberine",
      "-",
      "9.1",
      "-",
      ">150",
      "SARS-CoV-2 (BavPat1 isolate)",
      "Vero E6",
      "-",
      "Plaque assay",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "-",
      "Obatoclax",
      "-",
      "0.067",
      "-",
      "7.8",
      "SARS-CoV-2 (BavPat1 isolate)",
      "Vero E6",
      "-",
      "Plaque assay",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "-",
      "Berberine",
      "-",
      "23.2",
      "-",
      "-",
      "SARS-CoV2/human/Nijmegen/1/2020",
      "Vero E6",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "-",
      "Obatoclax",
      "-",
      "<0.040",
      "-",
      "-",
      "SARS-CoV2/human/Nijmegen/1/2020",
      "Vero E6",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "-",
      "Berberine",
      "-",
      "10.7",
      "-",
      "87.3",
      "SARS-CoV-2 (BavPat1 isolate)",
      "primary nasal epithelial cells",
      "-",
      "qRT-PCR",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "-",
      "Obatoclax",
      "-",
      "0.2",
      "-",
      "6.5",
      "SARS-CoV-2 (BavPat1 isolate)",
      "primary nasal epithelial cells",
      "-",
      "qRT-PCR",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "-",
      "Losartan",
      "-",
      "13.65",
      "-",
      "-",
      "SARS-CoV-2 (2019-nCoV/USA-WA1/2020; MN985325.1)",
      "Vero E6",
      "-",
      "-",
      "-",
      "https://doi.org/10.1101/2020.12.27.424507"
    ],
    [
      "-",
      "Dinaciclib",
      "-",
      "0.08",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.7",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "AZD5438",
      "-",
      "3.18",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "GC376 sodium",
      "-",
      "4.11",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "SC66",
      "-",
      "5.51",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "BFH772",
      "-",
      "7.34",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Camostat mesylate",
      "-",
      "8.57",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "B02",
      "-",
      "8.81",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "GKT137831",
      "-",
      "11.1",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Cantharidin",
      "-",
      "19.2",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Budesonide",
      "-",
      "20.5",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Cyclosporin A",
      "-",
      "25",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "CCT196969",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "TP0903",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "KC7F2",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "AT9283",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "APY29",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Tulipalin A",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Bis(3-aminopropyl)- amine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "JNK-IN-7",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Levistilide A",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "PF-562271",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "AZD9496",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "RGB-286638 free base",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Idazoxan hydrochloride",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Ginkgolic acid C15:1",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Sulbentine",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Lansoprazole",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "JNK-IN-8",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "EsOmeprazole Magnesium",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Lansoprazole",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Exemestane",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Celecoxib",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Calcitriol",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "(R)-Ruxolitinib",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Trilostane",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Disulfiram",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Dasabuvir",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Megestrol acetate",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Atracurium besylate",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Efavirenz",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Progesterone",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Ethoxzolamide",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Drospirenone",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Tretinoin",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Dabrafenib",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Grazoprevir",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "-",
      "Fenofibrate",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 strain hCOV-19/England/2/2020",
      "VeroE6",
      "-",
      "immunoimmaging",
      "-",
      "https://doi.org/10.1101/2021.01.10.426114"
    ],
    [
      "-",
      "JQ1",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (BetaCoV/France/IDF0372/2020 strain)",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.19.427194;"
    ],
    [
      "-",
      "ABBV-744",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (BetaCoV/France/IDF0372/2020 strain)",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.19.427194;"
    ],
    [
      "-",
      "Exebryl-1",
      "-",
      "10",
      "-",
      "52",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "-",
      "Piroxantrone",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "-",
      "MMV1580853",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "-",
      "Exebryl-1",
      "-",
      "-",
      "-",
      "61",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "-",
      "Exebryl-1",
      "-",
      "65.6",
      "-",
      ">200",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "immunostaining",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "-",
      "Sirolimus",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "-",
      "Metformin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "-",
      "N-hydroxycytidine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "-",
      "Chloroquine",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "-",
      "Dexamethasone",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "-",
      "4beta-hydroxycholesterol",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "-",
      "22(S)-hydroxycholesterol",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "-",
      "22(R)-hydroxycholesterol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "-",
      "24(S)-hydroxycholesterol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "-",
      "27-hydroxycholesterol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "-",
      "Oxysterol analogues",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "-",
      "Compound 1",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "Caco-2",
      "-",
      "qRT-PCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.05.429959"
    ],
    [
      "-",
      "GRL0617",
      "-",
      "21.7",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "XR8-23",
      "-",
      "2.8",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "XR8- 24",
      "-",
      "2.5",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "XR8- 89",
      "-",
      "11.3",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "GRL0617",
      "-",
      ">20",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "A549-hACE2 c",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "XR8-23",
      "-",
      "1.4",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "A549-hACE2 c",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "XR8- 24",
      "-",
      "1.2",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "A549-hACE2 c",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "-",
      "Azacytidine,5-",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Plerixafor",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Mebrofenin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Mavorixafor(trihydrochloride)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Plerixafor (octahy- 137drochloride) ",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Gliclazide",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Cyclen",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Kasug-138 amycin (hydrochloride hydrate)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Saroglitazar Magne- 139 sium",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "Memantine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "-",
      "SNX-5422",
      "-",
      "0.38",
      "-",
      "91.97",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Vero E6",
      "0.01-0.02",
      "qRT-PCR",
      "flow cytometry",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "-",
      "SNX-5422",
      "-",
      "0.4",
      "-",
      ">100",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Calu-3",
      "0.01-0.02",
      "qRT-PCR",
      "flow cytometry",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "-",
      "SNX-5422",
      "-",
      "0.2",
      "-",
      "-",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Vero E6",
      "0.01-0.02",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "-",
      "SNX-5422",
      "-",
      "0.2",
      "-",
      "-",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Calu-3",
      "0.01-0.02",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "-",
      "WIN 55,212-2",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV-2 (GenBank accession no. MT710714)",
      "iPSC-derived cardiomyocytes",
      "0.1",
      "pcr, immunifluorescence,ELISA",
      "LDH",
      "https://doi.org/10.1101/2021.02.20.431855"
    ],
    [
      "-",
      "NE-100",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (GenBank accession no. MT710714)",
      "iPSC-derived cardiomyocytes",
      "0.1",
      "Plaque assay, immunifluorescence",
      "LDH",
      "https://doi.org/10.1101/2021.02.20.432092"
    ],
    [
      "-",
      "SF2523",
      "-",
      "1.52",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      " UNCN1T",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.06",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      " UNCN1T",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "-",
      "SF2523+ Remdesivir",
      "-",
      "0.62",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      " UNCN1T",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "-",
      "SF2523",
      "-",
      "1.02",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      "Vero-STAT1 knockout",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.03",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      "Vero-STAT1 knockout",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "-",
      "SF2523+ Remdesivir",
      "-",
      "1.21",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      "Vero-STAT1 knockout",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "-",
      "6-formylindolo(3,2-b)carbazole (FICZ)",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV2/JP/Hiroshima-46059T/2020",
      "Vero E6/TMPRSS2",
      "0.01",
      "Immunoblotting analysis",
      "-",
      "https://doi.org/10.1101/2021.03.04.433658"
    ],
    [
      "-",
      "Omeprazole (OMP)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV2/JP/Hiroshima-46059T/2020",
      "Vero E6/TMPRSS2",
      "0.01",
      "Immunoblotting analysis",
      "-",
      "https://doi.org/10.1101/2021.03.04.433658"
    ],
    [
      "-",
      "Cobicistat",
      "-",
      "0.58-8.76",
      "-",
      "38.66-53",
      " SARS-CoV-2,BavPat1/2020",
      "Calu-3, Vero E6, T84",
      "-",
      "qPCR",
      "MTT",
      "https://doi.org/10.1101/2021.03.09.434219;"
    ],
    [
      "-",
      "Cobicistat + Remdesivir",
      "-",
      "-",
      " active",
      "-",
      " SARS-CoV-2,BavPat1/2021",
      "Vero E6, T84",
      "0.5",
      "qPCR",
      "MTT",
      "https://doi.org/10.1101/2021.03.09.434219;"
    ],
    [
      "-",
      "Cannabidiol",
      "-",
      "1.27",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "-",
      "Cannabidiol",
      "-",
      "4.96",
      "-",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "0.1",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "-",
      "7-OH-CBD",
      "-",
      "3.6",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "-",
      "URMC-099",
      "-",
      "0.21",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "-",
      "KPT-9274",
      "-",
      "2.14",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "-",
      "Ebselen",
      "-",
      "4.67",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "-",
      "Ebselen derivative MR6-7-2",
      "-",
      "4.5",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "-",
      "Ebselen derivative MR6-18-4",
      "-",
      "3.74",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "-",
      "Ebselen derivative MR6-26-2",
      "-",
      "3.17",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "-",
      "Ebselen derivative MR6-31-2",
      "-",
      "1.78",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "-",
      "Apabetalone",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "-",
      "JQ1",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "-",
      "Camostat",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "-",
      "Clomipramine",
      "-",
      "4.4",
      "-",
      "-",
      "SARS-CoV-2 strain JPN/TY/WK-521",
      "Vero E6/TMPRSS2",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2021.03.13.435221"
    ],
    [
      "-",
      "Ibudilast",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain JPN/TY/WK-521",
      "Vero E6/TMPRSS2",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2021.03.13.435221"
    ],
    [
      "-",
      "Epigallocatechin Gallate",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (isolate USA-WA1/2020, NR-52281) a",
      "Calu-3",
      "-",
      "Plaque assay, RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2021.03.17.435637"
    ],
    [
      "-",
      "Diclazuril",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "-",
      "Lenvatinib",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "-",
      "Lenvatinib+Remdesivir",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "-",
      "Ramelteon",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "-",
      "Oprea1",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "-",
      "Acriflavine",
      "-",
      "0.064",
      "-",
      "3.4",
      "SARS-CoV-2 strain 026V-03883",
      "Vero-CCL81",
      "-",
      "RT-qPCR",
      "XTT",
      "https://doi.org/10.1101/2021.03.20.436259"
    ],
    [
      "-",
      "Acriflavine",
      "-",
      "0.086",
      "-",
      "3.1",
      "SARS-CoV-2 strain 026V-03883",
      "A549-ACE2+",
      "-",
      "RT-qPCR",
      "XTT",
      "https://doi.org/10.1101/2021.03.20.436259"
    ],
    [
      "-",
      "Acriflavine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 strain 026V-03883",
      "Human airway epithelial (HAE)",
      "-",
      "RT-qPCR",
      "XTT",
      "https://doi.org/10.1101/2021.03.20.436259"
    ],
    [
      "-",
      "Halofuginone",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Hep3B",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginone",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2021",
      "primary human bronchial epithelial cells",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginone",
      "-",
      "0.109",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2022",
      "Huh 7.5",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginone",
      "-",
      "0.013",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2023",
      "Vero E6",
      "-",
      " Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginone",
      "-",
      "0.0349",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2024",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginone, 2R,3S-(+)",
      "-",
      "0.012",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2024",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginone, 2S,3R-(-) ",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2024",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "ProSA",
      "-",
      "2.4",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2025",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "Halofuginol",
      "-",
      "0.672",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2026",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "-",
      "MS023",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate RIM-1 (GenBank accession number: MW599736) a",
      "VeroE6",
      "-",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2021.03.24.436822"
    ],
    [
      "-",
      "Sulforaphane",
      "-",
      "2.4",
      "-",
      "-",
      "SARS-CoV-2/Wuhan-Hu-1",
      "Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.25.437060"
    ],
    [
      "-",
      "Galidesivir",
      "-",
      "16.5-106.5",
      "-",
      "-",
      "SARS-CoV-2 PHE2/GLA1",
      "VeroE6-ACE2/A549-NPro-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.03.25.436935"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.07-3.17",
      "-",
      "-",
      "SARS-CoV-2 PHE2/GLA2",
      "VeroE6-ACE2/A549-NPro-ACE3",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.03.25.436935"
    ],
    [
      "-",
      "HydroxyChloroquine",
      "-",
      "9.24-24.11",
      "-",
      "-",
      "SARS-CoV-2 PHE2/GLA3",
      "VeroE6-ACE2/A549-NPro-ACE4",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.03.25.436935"
    ],
    [
      "-",
      "Supramolecular cylinders, [M2L3]4+ 266 (M=Ru, Ni)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 virus England 2",
      "Vero cells",
      "-",
      "immuno imaging",
      "MTT",
      "https://doi.org/10.1101/2021.03.30.437757"
    ],
    [
      "-",
      "MU-UNMC-1 a",
      "-",
      "0.67,1.16",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "human bronchial epithelial cell line (UNCN1T),",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "-",
      "MU-UNMC-2",
      "-",
      "1.72, 0.89 ",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "human bronchial epithelial cell line (UNCN1T),",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "-",
      "MU-UNMC-1 a",
      "-",
      "5.35, 2.94",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "Vero- STAT1 knockout cells",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "-",
      "MU-UNMC-2",
      "-",
      "1.63, 0.54",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "Vero- STAT1 knockout cells",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "-",
      "Amiloride",
      "-",
      "11.28",
      "-",
      ">100",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "-",
      "Dimethyl amiloride",
      "-",
      "1.716",
      "-",
      ">100",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52282",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "-",
      "Ethyl isopropyl amiloride",
      "-",
      "0.714",
      "-",
      "60.57",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52283",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "-",
      "Hexamethylene amiloride",
      "-",
      "0.653",
      "-",
      "13.86",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52284",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "-",
      "PF-03882845",
      "-",
      "10.97",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Inauhzin",
      "-",
      "12.96",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Inauhzin EC50+Remdesivir",
      "-",
      "11.25",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Trifluperidol",
      "-",
      "14.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Lomeguatrib",
      "-",
      "59.84",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "PF-03882845 EC50+Remdesivir",
      "-",
      "4.79",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Trifluperidol EC50+Remdesivir",
      "-",
      "5.05",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Lomeguatrib EC50+Remdesivir",
      "-",
      "44.14",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Patulin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438812"
    ],
    [
      "-",
      "Aurintricarboxylic acid",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438812"
    ],
    [
      "-",
      "NSC95397",
      "-",
      "-",
      "not active ",
      "<10",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438811"
    ],
    [
      "-",
      "Dihydrotanshinone I",
      "-",
      "8.148",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Ro 08-2750",
      "-",
      "20",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Cryptotanshinone",
      "-",
      ">200",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Tanshinone IIA",
      "-",
      ">200",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "GRL-0617",
      "-",
      "32.6",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Dihydrotanshinone I+Remdesivir",
      "-",
      "5.348",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Ro 08-2750+Remdesivir",
      "-",
      "22.7",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Beta-Lapachone",
      "-",
      "-",
      "toxic",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Cdk4 Inhibitor III",
      "-",
      "-",
      "toxic",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "-",
      "Suramin",
      "-",
      "9.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "-",
      "FPA-124",
      "-",
      "14",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438809"
    ],
    [
      "-",
      "SSYA10-001",
      "-",
      "80.5",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "-",
      "Myricetin",
      "-",
      "31.6",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438811"
    ],
    [
      "-",
      "Suramin + Remdesivir",
      "-",
      "10.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438812"
    ],
    [
      "-",
      "FPA-124 + Remdesivir",
      "-",
      "16.2",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438813"
    ],
    [
      "-",
      "SSYA10-001 + Remdesivir",
      "-",
      "63.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438814"
    ],
    [
      "-",
      "Myricetin + Remdesivir",
      "-",
      "24.4",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438815"
    ],
    [
      "-",
      "GSK-650394 + 0.5 \u00b5M Remdesivir",
      "-",
      "8.5",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "C646 BH3I-1 + 0.5 \u00b5M Remdesivir",
      "-",
      "32",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "BH3I-1 + 0.5 \u00b5M Remdesivir ",
      "-",
      "61",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "MDK-83190  + 0.5 \u00b5M Remdesivir",
      "-",
      "77",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "Cefsulodin  + 0.5 \u00b5M Remdesivir",
      "-",
      "120",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "GSK-650394",
      "-",
      "7.6",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "C646",
      "-",
      "19",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "BH3I-1",
      "-",
      "77",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "MDK-83190",
      "-",
      "81",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "Cefsulodin",
      "-",
      "108",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "-",
      "Calpain Inhibitor I",
      "-",
      "0.28",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "-",
      "Z-VAD-FMK",
      "-",
      "138",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "-",
      "Z-AVLD-FMK",
      "-",
      "66",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "-",
      "Calpain Inhibitor I + 0.5 \u00b5M Remdesivir",
      "-",
      "0.34",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "-",
      "Z-VAD-FMK + 0.5 \u00b5M Remdesivir",
      "-",
      "92.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "-",
      "Z-AVLD-FMK + 0.5 \u00b5M Remdesivir",
      "-",
      "65.2",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "-",
      "Camostat",
      "-",
      ">5",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Nafamostat",
      "-",
      ">5",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Aprotinin",
      "-",
      ">50",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Bromhexine hydrochloride",
      "-",
      "20-21",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.11-0.20",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "5.22-6.15",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "4.48-7.70",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "EIDD-2801",
      "-",
      "24.4->50",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "EIDD-1931",
      "-",
      "1.34-1.70",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Camostat",
      "-",
      "0.10-0.17",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Nafamostat",
      "-",
      "0.02",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Aprotinin",
      "-",
      "0.7-1.04",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Bromhexine hydrochloride",
      "-",
      "12.2-29.44",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "1.21-1.59",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Ciclesonide",
      "-",
      "5.54-8.98",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "0.42-0.73",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "EIDD-2801",
      "-",
      "1.7-3.4",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "EIDD-1931",
      "-",
      "0.24-0.35",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "-",
      "7-hydroxystaurosporine",
      "-",
      "<5.09",
      "-",
      "-",
      "SARS-CoV2 ",
      "Caco2-ACE2",
      "-",
      "Immunofluorescence imaging",
      "-",
      "https://doi.org/10.1101/2021.04.15.440004"
    ],
    [
      "-",
      "Bafetinib",
      "-",
      "<1.22",
      "-",
      "-",
      "SARS-CoV2 ",
      "Caco2-ACE2",
      "-",
      "Immunofluorescence imaging",
      "-",
      "https://doi.org/10.1101/2021.04.15.440004"
    ],
    [
      "-",
      "Bafetinib+7-hydroxystaurosporine",
      "-",
      "0.65",
      "-",
      "-",
      "SARS-CoV2 ",
      "Caco2-ACE3",
      "-",
      "Immunofluorescence imaging",
      "-",
      "https://doi.org/10.1101/2021.04.15.440004"
    ],
    [
      "-",
      "Celastrol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 ( Brazil/SPBR-02/2020 strain)",
      "Vero CCL-81, Vero CCL-81-ACE2,  Caco-2, and  Calu-3",
      "-",
      "RT-PCR",
      "Alamar Blue",
      "https://doi.org/10.1101/2021.04.20.439992"
    ],
    [
      "-",
      "Narasin ",
      "-",
      "0.07",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "K-strophanthidin  ",
      "-",
      "0.75",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Ouabain  ",
      "-",
      "0.045",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "VE-822 ",
      "-",
      "1.33",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Nanchangmycin  ",
      "-",
      "0.15",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Obatoclax  ",
      "-",
      "0.048",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "BET-BAY-002  ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "BMS-986158 ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "CPI-0610",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Mivebresib",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Calpeptin ",
      "-",
      "2",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Proscillaridin ",
      "-",
      "0.001",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "VBY-825 ",
      "-",
      "1.8",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Talniflumate ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Pralatrexate ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "BAY-2402234 ",
      "-",
      "0.006",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Sangivamycin ",
      "-",
      "0.045",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Anisomycin ",
      "-",
      "0.049",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Eliglustat",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "A-485 ",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "BIX-01294 ",
      "-",
      "0.82",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "AT13387 ",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Ganetespib",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "NVP-HSP990",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "SNX-2112",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Apilimod (STA5326) ",
      "-",
      "0.1",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Omipalisib (GSK2126458) ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Deslanoside ",
      "-",
      "0.165",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Mepacrine  ",
      "-",
      "1.33",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "APY0201 ",
      "-",
      "0.3",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "MG-132 ",
      "-",
      "0.15",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Bruceantin ",
      "-",
      "0.11",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Emetine ",
      "-",
      "0.125",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Harringtonine ",
      "-",
      "0.12",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Homoharringtonine ",
      "-",
      "0.43",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Tioguanine  ",
      "-",
      "1.2",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Niclosamide  ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Bafilomycin A1 ",
      "-",
      "0.12",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "GSK-2660614",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "-",
      "Enzalutamide",
      "-",
      "-",
      "not active",
      "-",
      "SARSCoV-2/human/Liverpool/REMRQ0001/2020",
      "differentiated primary human airway",
      "-",
      "RT-qPCR",
      "LDH",
      "https://doi.org/10.1101/2021.04.23.440619"
    ],
    [
      "-",
      "Camostat mesylate",
      "-",
      "-",
      "active",
      "-",
      "SARSCoV-2/human/Liverpool/REMRQ0001/2020",
      "differentiated primary human airway",
      "-",
      "RT-qPCR",
      "LDH",
      "https://doi.org/10.1101/2021.04.23.440619"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.06",
      "-",
      "-",
      "SARS-CoV-2,Wuhan D614",
      "VeroE6 TMPRSS2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.13",
      "-",
      "-",
      "SARS-CoV-2, BavPat D614G ",
      "VeroE6 TMPRSS2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.08",
      "-",
      "-",
      "SARS-CoV-2, UK B.1.1.7",
      "VeroE6 TMPRSS2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "-",
      "Niclosamide",
      "-",
      "0.07",
      "-",
      "-",
      "SARS-CoV-2,SA 96 B.1.351",
      "VeroE6 TMPRSS3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "-",
      "Iota-carrageenan",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, provided by Dr. Sandra Gallegos (National University of\n79 C\u00f3rdoba, Argentina)",
      "Calu-3",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.04.27.441512"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "2.5",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "GC-376",
      "-",
      "3.9",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "hopeaphenol",
      "-",
      "10.2",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "vatalbinoside A",
      "-",
      "13.8",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "vaticanol B",
      "-",
      "37",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 ",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "Resveratrol",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "hopeaphenol",
      "-",
      "14.8",
      "-",
      "-",
      "B.1.1.7 (England/204820464/2020; \u201cUK variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "hopeaphenol",
      "-",
      "2.3",
      "-",
      "-",
      "B.1.351 (KRISP-K005325/2020; \u201cSouth Africa variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.5",
      "-",
      "-",
      "B.1.1.7 (England/204820464/2020; \u201cUK variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "Remdesivir",
      "-",
      "1.4",
      "-",
      "-",
      "B.1.351 (KRISP-K005325/2020; \u201cSouth Africa variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "-",
      "Camostat mesylate",
      "-",
      "0.0106",
      "-",
      "-",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0130 ",
      "-",
      "0.0301",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0438",
      "-",
      "0.0357",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0386",
      "-",
      "0.0023",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0385",
      "-",
      "0.0028",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0385(OH)",
      "-",
      ">1",
      "-",
      "-",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0385",
      "-",
      "0.0034",
      "-",
      "-",
      "B.1.1.7",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0385",
      "-",
      "0.0131",
      "-",
      "-",
      "B.1.351",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "N-0385",
      "-",
      "0.0052",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "-",
      "Cyclo(DLK)R-kbt",
      "-",
      "0.66",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "-",
      "Ac-IQFR-kbt",
      "-",
      "0.102",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "-",
      "Ac-QFR-kbt",
      "-",
      "0.105",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "-",
      "Ac-PQFR-kbt",
      "-",
      "0.052",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "-",
      "Ac-GQFR-kbt",
      "-",
      "0.074",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "-",
      "N-butyl deoxynojirimycin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (USA-WA1/2020 strain)",
      " A549ACE2",
      "-",
      "imaging",
      "-",
      "https://doi.org/10.1101/2021.05.14.444190"
    ],
    [
      "-",
      "Ureido-N-hexyl deoxynojirimycine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (USA-WA1/2020 strain)",
      " A549ACE2",
      "-",
      "imaging",
      "-",
      "https://doi.org/10.1101/2021.05.14.444190"
    ],
    [
      "-",
      "Allicin",
      "diallyl thiosulfinate",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Munich isolate (CSpecVir985)",
      "Calu-3, Vero E6",
      "-",
      "RT-qPCR, microscopy imaging",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2021.05.15.444275"
    ],
    [
      "-",
      "Ivermectin",
      "-",
      "1.9",
      "-",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "-",
      "Moxidectin",
      "-",
      "4.5",
      "-",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "-",
      "Ivermectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Calu-3",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "-",
      "Moxidectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Calu-3",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "-",
      "Ivermectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "primary human bronchial epithelial cells (PBECs)",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "-",
      "Moxidectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "primary human bronchial epithelial cells (PBECs)",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "-",
      "Probenecid",
      "-",
      "0.75",
      "-",
      "-",
      "SARS-CoV-2 isolate nCoV-WA1-2020",
      "Vero E6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.05.21.445119"
    ],
    [
      "-",
      "Probenecid",
      "-",
      "0.0013",
      "-",
      "-",
      "SARS-CoV-2 isolate nCoV-WA1-2020",
      "normal human bronchoepithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.05.21.445119"
    ],
    [
      "-",
      "Defensin HNP1",
      "-",
      "10.3",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 ",
      "Vero E6",
      "-",
      "Flow cytometry",
      "-",
      "https://doi.org/10.1101/2021.05.27.445985"
    ]
  ]
}